Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3018301	s-tes-vlik	pmol/l (pmol/l)	2285	3055	0.00%
3018301	s-testo-v	pmol/l (pmol/l)	1082	1390	0.00%
3018301	s-hstesvl	pmol/l (pmol/l)	73	86	0.00%
3018301	s-testovi	pmol/l (pmol/l)	62	85	0.00%
3018301	testosteroni,vapaa,laskettu,herkkämenetelmä	pmol/l (pmol/l)	15	15	0.00%
3018301	s-testosteroni,vapaa	pmol/l (pmol/l)	10	11	0.00%	Distribution not available
3018301	testosteroni,vapaa	pmol/l (pmol/l)	9	11	0.00%	Distribution not available
3018301	s-testosteroni,vapaa(pi)	pmol/l (pmol/l)	5	11	0.00%	Distribution not available
3018301	s-testosteroni,vapaa	nmol/l (pmol/l)	5	5	0.00%	Distribution not available	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Testicular dysfunction

238

334

8.12

164.59

1.7

1.3

179.27

204.81

pmol/l

0.42

238

334

Disorders of other endocrine glands

477

1245

3.82

154.41

1.6

1.3

152.68

181.38

pmol/l

2.27

477

1245

Testicular hypofunction

211

301

8.00

143.89

1.7

1.3

178.46

210.54

pmol/l

0.49

211

301

Hypopituitarism

190

364

5.48

94.64

1.7

1.3

138.56

204.60

pmol/l

1.77

190

364

Hypogonadotropic hypogonadism

157

256

6.86

94.19

1.7

1.4

152.32

212.85

pmol/l

0.95

157

256

Sleep apnoea

744

2284

2.07

67.33

1.4

1.3

200.35

184.28

pmol/l

0.18

744

2284

Exclusions for E4_PCOS_BROAD

209

586

3.63

63.09

1.7

1.3

139.63

186.38

pmol/l

1.86

209

586

Sleep apnoea, including avohilmo

752

2275

2.01

62.67

1.4

1.3

204.05

184.45

pmol/l

0.23

752

2275

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

239

857

2.81

47.76

1.6

1.3

145.45

177.88

pmol/l

1.59

239

857

Sleep disorders (combined)

730

2088

1.83

45.19

1.4

1.3

174.42

183.94

pmol/l

0.32

730

2088

Any death

1867

0.22

35.74

1.3

96.70

174.98

pmol/l

5.63

1867

Exposure to other specified factors

561

2915

1.66

27.42

1.4

1.3

175.30

186.20

pmol/l

0.50

561

2915

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

382

2014

1.84

27.31

1.4

1.3

158.82

180.67

pmol/l

2.30

382

2014

Other antidepressants

695

2215

1.61

27.11

1.4

1.3

184.08

191.98

pmol/l

0.18

695

2215

Other diseases of upper respiratory tract

659

2186

1.57

23.88

1.4

1.3

165.27

181.40

pmol/l

1.83

659

2186

Behavioural syndromes associated with physiological disturbances and physical factors

617

2667

1.57

23.29

1.5

1.3

227.42

176.32

pmol/l

0.60

617

2667

Episodal and paroxysmal disorders

665

2167

1.56

23.07

1.4

1.3

169.54

186.34

pmol/l

0.61

665

2167

Dislocation, sprain and strain of joints and ligaments of knee

464

2572

1.64

21.92

1.4

1.3

180.17

187.27

pmol/l

0.24

464

2572

Sleep disorders

589

2613

1.56

21.57

1.4

1.3

229.50

176.83

pmol/l

0.59

589

2613

Selective serotonin reuptake inhibitors

653

2217

1.54

21.26

1.4

1.3

181.14

191.99

pmol/l

0.25

653

2217

Coxibs

190

447

2.24

20.59

1.6

1.2

214.51

192.44

pmol/l

0.19

190

447

Insomnia

568

2577

1.54

19.78

1.5

1.3

230.92

177.12

pmol/l

0.58

568

2577

Chronic rhinitis, nasopharyngitis and pharyngitis

187

935

2.01

17.85

1.4

1.3

165.37

185.20

pmol/l

0.88

187

935

Heart failure, not strict

147

2031

0.48

17.20

1.5

1.3

135.81

174.45

pmol/l

2.89

147

2031

Depression or dysthymia

426

1457

1.60

16.96

1.4

1.3

187.95

183.04

pmol/l

0.08

426

1457

Impotence

314

2.77

16.58

1.8

1.3

168.20

194.83

pmol/l

0.39

314

Deviated nasal septum

275

1593

1.74

16.52

1.4

1.3

160.57

182.52

pmol/l

1.58

275

1593

Chronic sinusitis

236

1318

1.80

16.05

1.4

1.3

157.59

181.25

pmol/l

1.58

236

1318

Recurrent or chronic depression

279

1124

1.73

15.65

1.4

1.3

186.24

188.14

pmol/l

0.02

279

1124

Heart failure,strict

1391

0.40

15.41

1.5

1.3

142.38

175.64

pmol/l

1.36

1391

Schizophrenia

930

0.15

15.33

1.3

168.31

194.87

pmol/l

0.33

930

Abnormalities of breathing

561

2191

1.47

15.27

1.4

1.3

154.83

180.62

pmol/l

5.74

561

2191

Heart failure, strict

1396

0.41

15.15

1.5

1.3

142.24

173.13

pmol/l

1.25

1396

Insulin medication

154

2462

0.52

15.07

1.3

132.79

192.48

pmol/l

4.34

154

2462

Special screening examination for infectious and parasitic diseases

272

1166

1.71

14.84

1.4

1.3

182.03

210.36

pmol/l

0.65

272

1166

Diseases of male genital organs

641

2267

1.43

14.81

1.4

1.3

180.72

201.10

pmol/l

0.93

641

2267

All-cause Heart Failure

1361

0.41

14.74

1.5

1.3

138.20

173.14

pmol/l

1.59

1361

Testicular dysfunction, other/unspecified

6.32

14.54

2.3

1.3

183.48

173.80

pmol/l

0.16

Exposure to unspecified factor

602

2898

1.42

13.99

1.4

1.3

171.27

186.90

pmol/l

0.80

602

2898

Transport accidents

311

1612

1.61

13.87

1.4

1.3

174.69

197.62

pmol/l

0.68

311

1612

Insulin, combination of fast acting with intermediate-acting or long-acting

154

2592

0.54

13.46

1.3

132.79

189.32

pmol/l

3.93

154

2592

Chronic diseases of tonsils and adenoids

475

2046

1.47

13.25

1.4

1.3

171.53

182.72

pmol/l

0.83

475

2046

Mouth breathing

293

1832

1.61

13.21

1.5

1.3

160.22

177.42

pmol/l

1.39

293

1832

Schizophrenia or delusion

1682

0.41

13.16

1.2

1.3

137.97

204.94

pmol/l

2.54

1682

Schizophrenia, schizotypal and delusional disorders

1680

0.41

13.13

1.2

1.3

137.97

204.55

pmol/l

2.51

1680

Type 2 diabetes, wide definition

202

2183

0.58

12.93

1.4

1.3

116.50

189.03

pmol/l

6.14

202

2183

Injuries to the shoulder and upper arm

535

2917

1.42

12.87

1.4

1.3

173.07

189.17

pmol/l

0.81

535

2917

Restless leg syndrome

302

2.53

12.80

1.4

166.75

191.32

pmol/l

0.33

302

Diabetes, insulin treatment (Kela reimbursement)

308

2841

0.64

12.79

1.4

1.3

156.84

189.72

pmol/l

0.52

308

2841

Irritable bowel syndrome

128

634

2.03

12.72

1.6

1.3

149.57

182.93

pmol/l

1.19

128

634

Peripheral artery disease

1030

0.34

12.53

1.3

1.4

117.04

170.44

pmol/l

2.54

1030

Oxicams

123

330

2.13

12.26

1.4

1.2

140.06

176.59

pmol/l

3.06

123

330

Myocardial infarction, strict

1382

0.47

12.06

1.4

1.3

143.40

177.17

pmol/l

1.96

1382

Stroke, including SAH

113

1604

0.50

12.02

1.4

1.3

151.38

173.90

pmol/l

1.08

113

1604

Atherosclerosis, excluding cerebral and coronary sclerosis

899

0.32

11.79

1.3

1.4

116.52

170.99

pmol/l

2.22

899

Major coronary heart disease event excluding revascularizations

136

1668

0.54

11.78

1.4

1.3

143.57

176.30

pmol/l

2.60

136

1668

COPD

1181

0.40

11.77

1.2

1.3

151.49

173.44

pmol/l

0.52

1181

Other joint disorders

566

2124

1.39

11.52

1.4

1.3

178.21

195.66

pmol/l

0.40

566

2124

Polycystic ovarian syndrome, consortium definition

106

3.03

11.43

1.1

45.83

15.09

pmol/l

0.43

106

COPD, early/later onset

1179

0.40

11.41

1.3

1.4

148.92

170.70

pmol/l

0.50

1179

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

299

2692

0.66

11.29

1.4

1.3

160.11

192.06

pmol/l

0.48

299

2692

Mental and behavioural disorders due to alcohol, excluding acute intoxication

155

2695

0.57

11.29

1.4

1.3

172.57

186.79

pmol/l

0.46

155

2695

Acute sinusitis

310

1850

1.53

11.24

1.4

1.3

244.47

180.43

pmol/l

0.35

310

1850

Alcohol dependence

1538

0.43

11.12

1.3

140.28

179.36

pmol/l

1.88

1538

Stroke, excluding SAH

102

1462

0.50

11.04

1.4

1.3

150.21

174.30

pmol/l

1.05

102

1462

Schizophrenia or delusion, excluding more controls

1543

0.44

11.04

1.2

1.3

137.97

202.14

pmol/l

2.31

1543

COPD, hospital admissions

1164

0.40

11.00

1.3

1.4

148.92

171.47

pmol/l

0.53

1164

Depression medications

279

884

1.59

10.90

1.4

1.3

210.66

204.77

pmol/l

0.07

279

884

Myocardial infarction

108

1464

0.51

10.86

1.4

1.3

140.83

177.98

pmol/l

2.58

108

1464

Renal failure

1374

0.45

10.85

1.3

140.52

174.88

pmol/l

1.50

1374

Oter anti-inflammatory and antirheumatic agents, non-steroids

101

254

2.19

10.83

1.2

159.84

174.00

pmol/l

0.43

101

254

Disturbance of activity and attention

111

542

2.01

10.80

1.3

178.21

191.47

pmol/l

0.39

111

542

Exclusions for E4_PCOS_CONSORTIUM

246

950

1.62

10.79

1.6

1.3

132.65

176.21

pmol/l

2.77

246

950

Medical observation and evaluation for suspected diseases and conditions

447

1599

1.43

10.66

1.5

1.3

157.89

200.39

pmol/l

1.84

447

1599

Acetic acid derivatives and related substances

154

427

1.87

10.65

1.4

1.2

231.31

186.73

pmol/l

0.34

154

427

All chronic kidney diseases

109

1666

0.52

10.65

1.4

1.3

146.47

177.44

pmol/l

1.90

109

1666

Other chronic obstructive pulmonary disease

1115

0.41

10.63

1.3

148.92

173.09

pmol/l

0.57

1115

Hyperkinetic disorders, excluding more controls

113

533

1.99

10.60

1.3

177.46

195.22

pmol/l

0.59

113

533

Mental and behavioural disorders due to alcohol

186

2916

0.60

10.59

1.4

1.3

171.22

187.71

pmol/l

0.64

186

2916

Nonorganic sleeping disorders

138

750

1.85

10.54

1.4

1.3

163.68

182.49

pmol/l

0.59

138

750

Heart failure and coronary heart disease

1003

0.42

10.53

1.5

1.4

154.52

177.32

pmol/l

0.66

1003

Insulin, intermediate and long-acting

149

2493

0.57

10.42

1.3

1.4

134.90

190.06

pmol/l

3.56

149

2493

Alcohol use disorder, ICD-based

143

2505

0.57

10.41

1.4

1.3

174.23

187.96

pmol/l

0.40

143

2505

Nonorganic sleeping disorders, excluding more controls

138

756

1.84

10.28

1.4

1.3

163.68

180.40

pmol/l

0.84

138

756

Cerebrovascular diseases

162

1901

0.59

10.09

1.4

1.3

148.48

172.90

pmol/l

1.66

162

1901

Use of hypnotics and sedatives

606

2587

1.34

10.01

1.4

1.3

161.80

186.37

pmol/l

1.41

606

2587

214

3004

0.63

9.97

1.4

1.3

172.80

186.68

pmol/l

0.56

214

3004

Neurological diseases

506

1840

1.38

9.93

1.4

1.3

185.74

188.53

pmol/l

0.05

506

1840

COPD related to multimorbidity

969

0.38

9.88

1.3

1.4

145.63

170.14

pmol/l

0.46

969

Injuries to the wrist and hand

568

2807

1.34

9.78

1.3

165.08

188.19

pmol/l

1.36

568

2807

Other specific joint derangements/joint disorders

457

2051

1.39

9.69

1.4

1.3

155.17

194.33

pmol/l

2.33

457

2051

COPD, hospital admission 2, with asthma infections

821

0.33

9.61

1.3

108.44

171.59

pmol/l

2.57

821

Ischaemic Stroke, excluding all haemorrhages

1324

0.51

9.58

1.4

1.3

153.69

174.60

pmol/l

0.76

1324

Alcohol use disorder, Swedish definition

205

2927

0.63

9.57

1.4

1.3

170.53

185.79

pmol/l

0.61

205

2927

Hyperkinetic disorders

113

583

1.90

9.41

1.3

177.46

191.07

pmol/l

0.42

113

583

Heart failure and antihypertensive medication

759

0.40

9.38

1.6

1.3

145.16

187.28

pmol/l

1.45

759

Vasomotor and allergic rhinitis

207

1271

1.60

9.32

1.3

297.58

188.51

pmol/l

0.42

207

1271

Kela-code for severe mental illness

1807

0.52

9.25

1.3

150.25

200.46

pmol/l

1.89

1807

Symptoms and signs involving the circulatory and respiratory systems

589

2216

1.33

9.22

1.4

1.3

180.35

181.17

pmol/l

0.02

589

2216

Heart failure and bmi 25plus

866

0.44

9.17

1.4

127.40

167.17

pmol/l

1.14

866

Use of pramipexole

438

2.04

9.15

1.4

143.28

183.54

pmol/l

0.96

438

Irregular menses

103

2.99

8.98

1.1

57.08

15.36

pmol/l

0.43

103

Diabetes mellitus

340

2781

0.70

8.97

1.4

1.3

159.82

189.31

pmol/l

0.51

340

2781

COPD, hospital admissions 3, with asthma pneumonia sepsis

605

0.27

8.70

1.2

1.3

115.60

176.70

pmol/l

1.40

605

233

3035

0.67

8.68

1.4

1.3

169.77

187.11

pmol/l

0.78

233

3035

Ovarian dysfunction

6.59

8.64

1.2

1.0

13.70

12.10

pmol/l

0.27

Diabetes, varying definitions

341

2779

0.71

8.62

1.4

1.3

159.56

189.42

pmol/l

0.52

341

2779

Other chronic obstructive pulmonary disease, including avohilmo

1459

0.54

8.49

1.2

1.4

146.15

173.26

pmol/l

1.14

1459

Tinnitus

125

708

1.77

8.43

1.4

157.46

181.27

pmol/l

0.85

125

708

Diabetes medication

345

2814

0.71

8.41

1.4

1.3

151.61

188.93

pmol/l

0.71

345

2814

Other and unspecified tonsillitis

296

1701

1.45

8.39

1.3

172.80

182.60

pmol/l

0.56

296

1701

Codeine

547

2235

1.32

8.35

1.4

1.3

182.81

190.01

pmol/l

0.14

547

2235

Acute alcohol intoxication

1372

0.49

8.27

1.3

161.14

179.43

pmol/l

0.59

1372

Other disorders of penis

114

634

1.82

8.23

1.4

1.3

176.11

192.08

pmol/l

0.40

114

634

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

554

2714

1.31

8.11

1.3

186.61

184.54

pmol/l

0.04

554

2714

Excessive, frequent and irregular menstruation

3.60

8.02

1.1

9.13

21.52

pmol/l

0.91

Other extrapyramidal and movement disorders in other diseases

104

567

1.84

7.98

1.4

1.3

157.31

177.55

pmol/l

0.49

104

567

Renal tubulo-interstitial diseases

205

2273

0.66

7.97

1.4

1.3

142.78

172.00

pmol/l

2.84

205

2273

Polycystic ovarian syndrome

7.24

7.95

1.1

1.0

13.82

11.77

pmol/l

0.32

Other and unspecified nonorganic psychotic disorders

1092

0.44

7.95

1.1

1.4

126.97

194.80

pmol/l

3.49

1092

Inflammatory diseases of prostate (prostatitis)

126

730

1.74

7.94

1.7

1.3

179.65

187.36

pmol/l

0.20

126

730

Malignant neoplasm of bronchus and lung

346

0.22

7.92

1.1

1.4

149.90

189.85

pmol/l

—

346

Acne

392

2.02

7.90

1.2

1.4

184.20

183.25

pmol/l

0.02

392

Polyuria

117

664

1.77

7.88

1.4

1.3

153.42

182.66

pmol/l

0.96

117

664

COPD (mode)

809

0.42

7.87

1.3

150.29

184.43

pmol/l

0.72

809

Infections with a predominantly sexual mode of transmission, including avohilmo

236

1452

1.49

7.82

1.4

1.3

179.40

202.89

pmol/l

0.60

236

1452

Infections with a predominantly sexual mode of transmission

166

1034

1.61

7.80

1.4

1.3

164.40

183.61

pmol/l

0.87

166

1034

Non-ischemic cardiomyopathy

797

0.42

7.80

1.3

1.4

137.52

178.69

pmol/l

1.18

797

Hernia

523

2652

1.31

7.79

1.3

227.21

180.61

pmol/l

0.46

523

2652

Genitourinary diseases

526

2003

1.32

7.76

1.4

1.3

170.90

203.37

pmol/l

1.57

526

2003

Anogenital herpesviral [herpes simplex] infection, including avohilmo

266

2.23

7.67

1.6

1.4

156.53

150.67

pmol/l

0.13

266

Injury of muscle and tendon at shoulder and upper arm level

233

1576

1.48

7.65

1.4

1.3

162.65

176.19

pmol/l

0.80

233

1576

Codeine or tramadol medication

617

2610

1.29

7.62

1.4

1.3

180.38

185.41

pmol/l

0.10

617

2610

Type 1 diabetes

1396

0.51

7.61

1.3

156.10

186.00

pmol/l

1.43

1396

Other disorders of patella

101

556

1.83

7.55

1.4

1.3

142.25

172.65

pmol/l

2.06

101

556

Unspecified mental disorder

115

1948

0.59

7.53

1.3

147.22

198.48

pmol/l

2.28

115

1948

Hypertensive heart and/or renal disease

700

0.42

7.45

1.5

1.3

137.94

171.89

pmol/l

0.91

700

Insulin, fast-acting

1712

0.56

7.44

1.3

1.4

145.88

182.49

pmol/l

2.36

1712

Other menopausal disorders

9.92

7.38

1.2

1.0

15.01

8.62

pmol/l

—

Coronary atherosclerosis

180

1738

0.65

7.36

1.4

1.3

164.69

175.88

pmol/l

0.59

180

1738

Type 2 diabetes

326

2597

0.72

7.32

1.4

1.3

155.89

188.82

pmol/l

0.56

326

2597

Other disorders of lacrimal gland

126

748

1.69

7.25

1.5

1.3

162.08

174.32

pmol/l

0.24

126

748

Arthropathies

545

2124

1.30

7.20

1.4

1.3

182.04

195.66

pmol/l

0.28

545

2124

Insulin, fast-acting or short human

1695

0.57

7.19

1.3

1.4

145.88

181.66

pmol/l

2.26

1695

Chronic kidney disease

902

0.43

7.16

1.3

1.4

134.90

175.81

pmol/l

1.17

902

Hypertensive Heart Disease

647

0.40

7.11

1.5

1.3

140.30

172.62

pmol/l

0.70

647

Presence of cardiac and vascular implants and grafts

1203

0.56

7.11

1.4

1.3

136.60

169.90

pmol/l

2.01

1203

Gastro-oesophageal reflux disease

354

2195

1.36

7.10

1.4

1.3

161.34

187.40

pmol/l

1.10

354

2195

Other medical care

1270

0.55

7.07

1.3

1.4

147.42

176.11

pmol/l

1.11

1270

Chronic periodontitis, complicated

147

2247

0.64

6.99

1.4

1.3

141.57

174.04

pmol/l

2.45

147

2247

Disorders of lacrimal system

148

909

1.60

6.98

1.5

1.3

163.48

173.05

pmol/l

0.22

148

909

Sub-endpoint used in defining T1D endpoints

1336

0.53

6.96

1.3

156.10

186.23

pmol/l

1.25

1336

Dialysis, with operation codes

505

0.24

6.94

1.2

1.4

73.07

186.25

pmol/l

3.00

505

Malignant neoplasm of respiratory system and intrathoracic organs, including Hilmo

520

0.32

6.89

1.1

1.4

137.49

182.41

pmol/l

0.99

520

Type 2 diabetes, definitions combined, including avohilmo

311

2466

0.73

6.87

1.4

1.3

154.32

188.54

pmol/l

0.55

311

2466

Malignant neoplasm of bronchus and lung, including Hilmo

417

0.24

6.78

1.1

1.4

134.24

187.41

pmol/l

0.80

417

Temporomandibular joint disorders, including avohilmo

169

1061

1.55

6.78

1.3

152.78

175.96

pmol/l

1.16

169

1061

352

0.23

6.78

1.1

1.4

116.94

194.20

pmol/l

—

352

Medicines for HER+ breast cancer

3.03

6.71

1.6

1.3

167.10

108.87

pmol/l

0.87

Care involving dialysis

310

0.19

6.68

1.3

1.4

43.45

201.95

pmol/l

—

310

Cerebrovascular diseases (FINNGEN)

1108

0.57

6.68

1.4

1.3

165.33

177.03

pmol/l

0.40

1108

Acute upper respiratory infections of multiple and unspecified sites

393

2156

1.33

6.67

1.4

1.3

168.17

179.67

pmol/l

0.87

393

2156

Subjective visual disturbances

107

623

1.72

6.66

1.6

1.3

154.53

176.71

pmol/l

0.66

107

623

Mental and behavioural disorders due to psychoactive substance use

241

3111

0.71

6.61

1.4

1.3

161.35

188.64

pmol/l

1.51

241

3111

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

298

2747

0.73

6.60

1.4

1.3

239.03

175.76

pmol/l

0.33

298

2747

Ischaemic heart disease, wide definition

234

2052

0.70

6.60

1.4

1.3

161.03

174.70

pmol/l

0.92

234

2052

L02BG Aromatase inhibitors

3.58

6.59

1.7

1.3

169.44

121.21

pmol/l

0.49

Solid cancers

267

2182

0.72

6.57

1.3

162.34

176.48

pmol/l

0.98

267

2182

Malignant neoplasm of digestive organs, including Hilmo

1080

0.56

6.55

1.2

1.4

146.46

177.44

pmol/l

1.60

1080

Implicit Sepsis

224

2359

0.70

6.55

1.3

142.77

177.36

pmol/l

4.02

224

2359

Type 1 diabetes, wide definition

1195

0.52

6.50

1.2

1.3

166.81

187.43

pmol/l

0.74

1195

Haemorrhoids and perianal venous thrombosis

150

951

1.57

6.49

1.3

166.49

180.39

pmol/l

0.51

150

951

Malignant neoplasm of digestive organs

999

0.53

6.47

1.2

1.4

141.40

175.85

pmol/l

1.70

999

Myalgia

104

606

1.72

6.46

1.3

146.58

165.81

pmol/l

0.92

104

606

Continuous positive airway pressure

150

796

1.58

6.42

1.5

1.3

118.88

189.66

pmol/l

12.49

150

796

Hirsutism in women

14.44

6.41

1.0

16.37

11.31

pmol/l

—

Sexual dysfunction

3.09

6.40

1.6

1.4

174.52

170.29

pmol/l

0.04

Organic, including symptomatic, mental disorders

935

0.54

6.38

1.2

1.3

128.30

173.25

pmol/l

2.32

935

Nephropathy related operations

478

0.25

6.37

1.2

1.4

73.07

187.78

pmol/l

3.01

478

Other inflammation of eyelid, including avohilmo

217

1504

1.45

6.35

1.5

1.3

304.13

176.66

pmol/l

0.54

217

1504

Anogenital herpesviral [herpes simplex] infection

154

2.49

6.35

1.7

1.4

149.75

154.18

pmol/l

0.07

154

Bacterial pneumonia, not elsewhere classified

1284

0.57

6.34

1.3

155.84

180.09

pmol/l

1.09

1284

Substance abuse

238

3098

0.71

6.33

1.4

1.3

159.25

188.69

pmol/l

1.68

238

3098

Bacterial Sepsis

104

1429

0.60

6.32

1.3

134.25

177.54

pmol/l

2.92

104

1429

Early onset COPD

860

0.44

6.30

1.3

1.4

162.08

176.21

pmol/l

0.21

860

Sulfonylureas

685

0.44

6.26

1.4

1.3

119.33

171.67

pmol/l

1.30

685

Biguanides

300

2457

0.74

6.25

1.4

1.3

147.67

186.53

pmol/l

0.63

300

2457

Acute upper respiratory infections

490

2288

1.28

6.24

1.4

1.3

163.60

178.65

pmol/l

1.55

490

2288

Malignant neoplasm of respiratory system and intrathoracic organs

445

0.30

6.22

1.1

1.4

146.00

184.92

pmol/l

0.66

445

Other (not insulin) diabetes medications

317

2502

0.74

6.21

1.4

1.3

151.29

187.75

pmol/l

0.61

317

2502

Other diseases of intestines

598

2658

1.25

6.19

1.4

1.3

159.56

192.36

pmol/l

2.35

598

2658

Angina pectoris

144

1472

0.65

6.19

1.4

1.3

154.86

176.30

pmol/l

1.26

144

1472

Other arthrosis

286

1389

1.38

6.13

1.4

1.3

158.41

176.10

pmol/l

1.76

286

1389

Pain in joint

376

1743

1.33

6.12

1.4

1.3

156.10

196.26

pmol/l

1.90

376

1743

COPD, hospital admissions 1, only main diagnosis

792

0.47

6.12

1.3

1.4

171.52

170.89

pmol/l

0.01

792

Bacterial pneumoniae

1403

0.59

6.11

1.3

1.4

159.13

181.08

pmol/l

1.05

1403

Any dementia, excluding more controls

419

0.34

6.10

1.3

1.4

128.02

163.05

pmol/l

0.77

419

Type 1 diabetes, wide definition, subgroup 1

1168

0.53

6.08

1.2

1.3

166.81

187.05

pmol/l

0.72

1168

Allergic conjunctivitis

240

1642

1.41

6.07

1.4

1.3

185.13

181.74

pmol/l

0.14

240

1642

Solid cancers, including Hilmo

289

2287

0.73

6.07

1.3

163.81

188.27

pmol/l

1.09

289

2287

Secondary polycythaemia

2.98

6.03

1.8

1.3

161.72

165.46

pmol/l

0.04

All kidney diseases

308

2766

0.74

6.02

1.4

1.3

151.68

184.19

pmol/l

2.16

308

2766

Mycoses, including avohilmo

499

2999

1.27

5.96

1.3

166.89

187.13

pmol/l

1.21

499

2999

Aplastic and other anaemias

1125

0.54

5.95

1.4

132.40

169.41

pmol/l

1.65

1125

Other bacterial diseases

328

2879

0.75

5.92

1.4

1.3

170.08

186.30

pmol/l

0.23

328

2879

Soft tissue disorders

579

2369

1.25

5.88

1.4

1.3

181.40

191.98

pmol/l

0.23

579

2369

Acute alcohol intoxication, ICD10

1143

0.53

5.87

1.4

1.3

166.86

182.21

pmol/l

0.42

1143

Voice disturbances

511

1.75

5.87

1.3

155.13

175.62

pmol/l

0.48

511

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

229

1558

1.41

5.84

1.3

185.93

182.98

pmol/l

0.11

229

1558

Malignant neoplasm

288

2276

0.74

5.82

1.3

160.39

177.16

pmol/l

1.28

288

2276

Any dementia

411

0.35

5.80

1.3

1.4

128.02

173.74

pmol/l

0.77

411

Persons encountering health services for specific procedures and health care

391

2984

0.77

5.80

1.3

162.41

187.54

pmol/l

1.61

391

2984

Hypertrichosis

9.26

5.79

1.0

1.1

15.64

82.27

pmol/l

1.15

Lyme disease

152

1002

1.52

5.77

1.3

157.46

176.05

pmol/l

0.82

152

1002

Lyme disease, including avohilmo

152

1002

1.52

5.77

1.3

157.46

176.05

pmol/l

0.82

152

1002

Malignant neoplasm

289

2279

0.74

5.75

1.3

160.64

177.26

pmol/l

1.27

289

2279

Implicit bacterial Sepsis, including avohilmo

100

1359

0.61

5.72

1.4

1.3

128.67

177.22

pmol/l

3.45

100

1359

Type 2 diabetes, definitions combined

316

2442

0.75

5.72

1.4

1.3

154.07

188.06

pmol/l

0.55

316

2442

Spirochaetal infections, other/unspecified, including avohilmo

153

1012

1.52

5.72

1.3

157.75

176.20

pmol/l

0.82

153

1012

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

311

2612

0.75

5.72

1.4

1.3

181.74

pmol/l

0.00

311

2612

Lung cancer and mesothelioma

407

0.29

5.70

1.1

1.3

146.56

193.27

pmol/l

0.73

407

Myocardial infarction, without ST-elevation

1140

0.56

5.68

1.4

128.77

171.54

pmol/l

2.61

1140

Type 2 diabetes, strict (exclude DM1)

317

2446

0.75

5.68

1.4

1.3

153.65

187.97

pmol/l

0.56

317

2446

Other diseases of urinary system

291

2193

0.74

5.66

1.4

1.3

145.28

173.94

pmol/l

2.97

291

2193

Contact with and exposure to communicable diseases

174

1179

1.47

5.66

1.4

1.3

336.92

183.91

pmol/l

0.52

174

1179

Other disorders of male genital organs

262

2.06

5.62

1.6

1.4

167.10

213.03

pmol/l

0.58

262

Pain in throat and chest

471

2194

1.27

5.60

1.3

181.91

181.11

pmol/l

0.01

471

2194

Other spirochaetal diseases

153

1017

1.51

5.60

1.3

156.73

175.91

pmol/l

0.86

153

1017

Erysipelas

185

2282

0.70

5.60

1.4

1.3

196.26

187.57

pmol/l

0.06

185

2282

Artrosis, including avohilmo

472

2032

1.27

5.57

1.4

1.3

235.94

176.53

pmol/l

0.51

472

2032

Chronic laryngitis and laryngotracheitis

289

1.98

5.57

1.5

1.3

168.45

195.99

pmol/l

0.33

289

Unstable angina pectoris

966

0.56

5.52

1.5

1.4

135.17

177.22

pmol/l

2.31

966

Other spirochaetal diseases, including avohilmo

155

1037

1.50

5.51

1.3

157.68

175.83

pmol/l

0.81

155

1037

Condition for Implicit Sepsis (Organ dysfunction codes)

284

2629

0.75

5.50

1.3

152.07

187.72

pmol/l

2.36

284

2629

Pain and other conditions associated with female genital organs and menstrual cycle

3.46

5.46

1.1

7.48

21.52

pmol/l

1.10

Diseases of arteries, arterioles and capillaries

173

1828

0.69

5.39

1.3

148.15

172.50

pmol/l

1.98

173

1828

Dermatophytosis, including avohilmo

385

2938

1.29

5.38

1.3

168.37

187.40

pmol/l

1.02

385

2938

Bacterial pneumonia (organism specified)

100

1454

0.62

5.38

1.3

1.4

155.32

176.92

pmol/l

1.07

100

1454

Shoulder lesions

403

1875

1.29

5.37

1.4

1.3

153.65

189.13

pmol/l

1.71

403

1875

Other predominantly sexually transmitted diseases, not elsewhere classified, including avohilmo

117

741

1.59

5.35

1.5

1.3

175.58

192.70

pmol/l

0.52

117

741

Dementia

526

0.45

5.32

1.2

1.4

115.71

176.74

pmol/l

1.76

526

Hypertrophy of breast in women and men

227

2.08

5.26

1.7

1.3

145.78

185.98

pmol/l

0.31

227

Status post-ami

681

0.50

5.24

1.4

1.3

129.22

181.83

pmol/l

2.00

681

Early onset COPD, excluding more controls

796

0.47

5.21

1.3

162.08

186.03

pmol/l

0.39

796

Periodontitis

354

2905

0.77

5.18

1.3

163.26

185.90

pmol/l

1.30

354

2905

Implicit Sepsis, including avohilmo

268

2552

0.75

5.15

1.3

148.53

187.44

pmol/l

2.59

268

2552

Degenerative diseases of the nervous system

413

0.38

5.15

1.1

1.4

142.70

176.51

pmol/l

0.52

413

Chronic periodontitis, including avohilmo

354

2902

0.78

5.10

1.3

163.72

185.99

pmol/l

1.27

354

2902

Schizoaffective disorder

297

0.27

5.07

1.6

1.4

203.41

208.25

pmol/l

—

297

Diseases of arteries, arterioles and capillaries (FINNGEN)

941

0.60

5.06

1.2

1.3

149.10

177.22

pmol/l

1.62

941

Polycystic ovarian syndrome, broad definition

3.17

5.03

1.1

12.51

12.23

pmol/l

0.05

Injuries to the knee and lower leg

611

2708

1.22

5.00

1.4

1.3

180.08

186.11

pmol/l

0.22

611

2708

Diseases of the musculoskeletal system and connective tissue

339

1299

1.31

4.98

1.5

1.3

199.96

206.24

pmol/l

0.07

339

1299

Malignant neoplasm, wide definition

310

2353

0.77

4.97

1.3

163.16

189.20

pmol/l

1.24

310

2353

STROKE

178

1693

0.71

4.96

1.4

1.3

157.66

178.06

pmol/l

1.28

178

1693

Coronary artery bypass grafting

662

0.51

4.94

1.3

157.05

183.85

pmol/l

0.68

662

Dentofacial anomalies [including malocclusion]

363

2213

1.28

4.94

1.2

1.3

167.21

193.75

pmol/l

1.14

363

2213

Any event in cancer register

310

2358

0.77

4.94

1.3

158.19

185.57

pmol/l

1.34

310

2358

Poisoning by drugs, medicaments and biological substances

1017

0.55

4.92

1.3

149.20

184.96

pmol/l

0.99

1017

Impingement syndrome of shoulder

119

773

1.54

4.91

1.4

1.3

145.81

167.43

pmol/l

1.20

119

773

Malignant neoplasm, including Hilmo

311

2356

0.77

4.90

1.3

163.22

189.28

pmol/l

1.25

311

2356

Implicit bacterial Sepsis

1230

0.62

4.89

1.3

1.4

122.71

177.36

pmol/l

3.90

1230

Migraine with aura

472

1.70

4.85

1.7

1.3

143.43

168.84

pmol/l

1.13

472

Dipeptidyl peptidase 4 (DPP-4) inhibitors

137

1580

0.68

4.85

1.3

115.04

173.95

pmol/l

10.75

137

1580

Care involving use of rehabilitation procedures

189

2350

0.72

4.76

1.3

168.41

187.82

pmol/l

0.77

189

2350

Acne vulgaris

321

1.85

4.73

1.2

1.3

205.35

188.13

pmol/l

0.43

321

Other predominantly sexually transmitted diseases, not elsewhere classified

538

1.64

4.70

1.5

1.3

160.60

189.68

pmol/l

0.77

538

Acne, including avohilmo

126

674

1.52

4.67

1.3

172.36

196.28

pmol/l

0.68

126

674

Other anaemias

1045

0.58

4.66

1.4

132.22

170.51

pmol/l

1.65

1045

Umbilical hernia

179

1275

1.41

4.66

1.4

1.3

154.88

174.96

pmol/l

1.07

179

1275

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

676

0.47

4.66

1.4

56.18

178.46

pmol/l

7.83

676

Explicit Sepsis, including avohilmo

1350

0.64

4.66

1.5

1.3

143.28

175.83

pmol/l

1.81

1350

Poisoning by medicine

895

0.53

4.64

1.3

142.96

184.51

pmol/l

1.17

895

Disorders of skin appendages

249

1860

1.33

4.63

1.3

170.47

192.96

pmol/l

0.74

249

1860

Injury of muscle and tendon at hip and thigh level

397

1.75

4.63

1.4

181.47

189.55

pmol/l

0.11

397

Other headache syndromes

149

1023

1.45

4.63

1.3

207.80

178.54

pmol/l

0.20

149

1023

Pacemaker

880

0.55

4.61

1.4

139.14

171.52

pmol/l

1.22

880

Lumbar disc prolapse

348

2016

1.28

4.60

1.4

1.3

161.59

189.24

pmol/l

1.27

348

2016

Explicit Sepsis

1319

0.63

4.60

1.4

1.3

141.88

175.51

pmol/l

1.84

1319

Abnormalities of heart beat

141

933

1.47

4.59

1.5

1.3

343.45

174.36

pmol/l

0.45

141

933

Dementia, including avohilmo

577

0.52

4.58

1.2

1.4

118.76

176.43

pmol/l

1.93

577

Used for control exclusion in common control thyroid runs

620

2589

1.21

4.58

1.4

1.3

199.60

184.78

pmol/l

0.14

620

2589

Benign neoplasms

591

2655

1.21

4.58

1.4

1.3

162.66

190.37

pmol/l

1.80

591

2655

Valvular heart disease excluding rheumatic fever

124

1313

0.67

4.58

1.4

1.3

153.95

170.79

pmol/l

0.96

124

1313

Herpesviral [herpes simplex] infections, including avohilmo

629

1.58

4.53

1.6

1.3

164.42

175.08

pmol/l

0.25

629

Other and unspecified anaemias

1037

0.59

4.50

1.4

132.22

170.65

pmol/l

1.66

1037

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

1091

0.58

4.50

1.2

1.3

128.26

178.98

pmol/l

2.62

1091

Hypothyroidism and >3 levothyroxin purchases

191

764

1.41

4.49

1.4

1.3

302.48

199.83

pmol/l

0.35

191

764

Hypothyroidism, levothyroxine purchases

191

764

1.41

4.49

1.4

1.3

302.48

199.83

pmol/l

0.35

191

764

Symptoms and signs involving speech and voice

106

687

1.55

4.45

1.3

146.48

173.99

pmol/l

0.98

106

687

Internal derangement of knee

207

1507

1.36

4.45

1.4

1.3

160.27

196.48

pmol/l

1.23

207

1507

Other intervertebral disc disorders

437

2095

1.24

4.44

1.4

1.3

165.22

188.35

pmol/l

1.04

437

2095

Diseases of the ear and mastoid process

622

2591

1.20

4.43

1.4

1.3

162.28

190.43

pmol/l

1.81

622

2591

Hypothyroidism (congenital or acquired)

191

767

1.40

4.38

1.4

1.3

303.08

199.57

pmol/l

0.35

191

767

Disorders of refraction and accommodation

140

962

1.45

4.36

1.3

184.69

184.03

pmol/l

0.01

140

962

Convulsions, not elsewhere classified

1165

0.61

4.34

1.3

163.46

181.65

pmol/l

0.71

1165

Non-rheumatic valve diseases

124

1297

0.68

4.33

1.4

1.3

153.95

170.41

pmol/l

0.93

124

1297

Extrapyramidal and movement disorders

138

952

1.45

4.30

1.4

160.62

172.55

pmol/l

0.40

138

952

Inflammatory diseases of female pelvic organs

122

2.13

4.29

1.0

1.1

9.64

31.02

pmol/l

0.75

122

Suicide or other Intentional self-harm

1050

0.59

4.28

1.2

1.3

132.17

185.21

pmol/l

2.73

1050

Retinal breaks without detachment

415

1.69

4.25

1.3

163.32

181.80

pmol/l

0.33

415

Other dorsopathies, not elsewhere classified

546

2342

1.21

4.22

1.4

1.3

189.30

190.44

pmol/l

0.02

546

2342

Pneumonia, organism unspecified

333

2878

0.79

4.21

1.4

1.3

157.46

188.93

pmol/l

1.87

333

2878

Other disorders of urethra and urinary system

107

1117

0.67

4.21

1.4

1.3

132.78

164.81

pmol/l

1.63

107

1117

Anti-inflammatory and antirheumatic products, non-steroids

135

458

1.49

4.20

1.3

1.2

174.37

194.14

pmol/l

1.20

135

458

Menorrhagia

3.24

4.19

1.1

1.0

8.47

12.25

pmol/l

1.06

Other enthesopathies

133

916

1.46

4.19

1.4

1.3

160.79

167.91

pmol/l

0.29

133

916

Missing teeth due to accident, extraction or parodontitis

156

1941

0.72

4.17

1.5

1.3

138.08

174.15

pmol/l

2.92

156

1941

Later onset COPD

371

0.39

4.16

1.2

1.4

121.15

150.55

pmol/l

0.53

371

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

2.80

4.11

1.0

1.2

9.07

20.06

pmol/l

1.26

Endocrine, nutritional and metabolic diseases

498

2064

1.22

4.09

1.4

1.3

179.16

189.86

pmol/l

0.24

498

2064

Septicaemia

1290

0.66

4.03

1.4

1.3

143.16

170.93

pmol/l

1.72

1290

Hyperplasia of prostate

290

1267

1.29

4.01

1.5

1.3

159.88

175.99

pmol/l

0.96

290

1267

Other disorders of prostate

105

2.40

3.99

1.4

197.70

246.28

pmol/l

0.23

105

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

1041

0.61

3.98

1.2

1.3

128.26

174.88

pmol/l

2.83

1041

Cardiomyopathy (excluding other)

520

0.44

3.98

1.3

159.73

170.09

pmol/l

0.17

520

Allergic rhinitis

158

1121

1.39

3.96

1.3

344.75

187.88

pmol/l

0.47

158

1121

Opioids

530

2270

1.21

3.95

1.4

1.3

184.32

191.14

pmol/l

0.13

530

2270

Other benign neoplasms of skin

133

930

1.43

3.90

1.4

1.3

150.74

173.86

pmol/l

1.09

133

930

Varicose veins of other sites

336

1.74

3.88

1.5

1.4

179.09

175.72

pmol/l

0.09

336

Alcohol withdrawal state with delirium

356

0.33

3.88

1.8

1.4

141.87

195.00

pmol/l

0.73

356

Noninflammatory disorders of female genital tract

2.62

3.86

1.1

11.30

21.52

pmol/l

0.68

Dorsopathies

555

2346

1.20

3.86

1.4

1.3

189.29

190.64

pmol/l

0.02

555

2346

Peripheral artery operations in Hilmo

325

0.31

3.85

1.3

1.4

102.54

188.36

pmol/l

—

325

Other disorders of veins

130

893

1.43

3.84

1.3

1.4

139.65

162.06

pmol/l

1.57

130

893

Intestinal infectious diseases

482

2971

1.21

3.83

1.4

1.3

166.90

187.20

pmol/l

1.13

482

2971

L04AA Selective immunosuppressants

765

0.55

3.83

1.4

1.3

134.49

184.59

pmol/l

1.95

765

Cardiomyopathies, Primary/intrinsic

496

0.44

3.79

1.2

1.3

163.17

170.88

pmol/l

0.11

496

Other septicaemia, including avohilmo

1172

0.65

3.78

1.5

1.3

138.21

170.51

pmol/l

2.02

1172

Other degenerative diseases of the nervous system

481

0.51

3.75

1.1

1.3

141.11

174.22

pmol/l

1.03

481

L04AD Calcineurin inhibitors

465

0.43

3.74

1.3

133.91

193.20

pmol/l

1.15

465

Intestinal infectious diseases, including avohilmo, including avohilmo

574

2689

1.19

3.73

1.4

1.3

176.15

185.18

pmol/l

0.20

574

2689

Acute renal failure

707

0.54

3.73

1.3

115.41

178.19

pmol/l

2.39

707

Inguinal hernia, bilateral

439

1.63

3.73

1.3

1.4

192.96

190.37

pmol/l

0.04

439

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

587

0.49

3.72

1.3

1.4

135.58

180.42

pmol/l

1.12

587

Monoamine oxidase A inhibitors

288

1.78

3.72

1.3

1.4

146.89

166.75

pmol/l

0.55

288

Unspecific neurodegenerative disorder

433

0.51

3.72

1.1

1.4

118.72

174.11

pmol/l

1.25

433

Tonsillectomy and adenotomy

337

1879

1.25

3.71

1.4

1.3

169.32

200.46

pmol/l

1.26

337

1879

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

372

3036

0.81

3.69

1.4

1.3

159.74

187.97

pmol/l

1.74

372

3036

Bacterial infection, other or unspecified

141

1648

0.72

3.69

1.3

124.81

172.63

pmol/l

5.69

141

1648

Other septicaemia

1136

0.65

3.68

1.4

1.3

136.36

169.95

pmol/l

2.06

1136

Calcific aortic valvular stenosis, including rheumatic fever

627

0.52

3.68

1.3

1.4

105.13

175.75

pmol/l

3.12

627

Inguinal or femoral hernia, bilateral

441

1.62

3.67

1.3

1.4

192.96

189.94

pmol/l

0.05

441

Type 1 diabetes, definitions combined

568

0.49

3.66

1.2

1.3

176.67

191.84

pmol/l

0.29

568

Calcific aortic valvular stenosis, operated

626

0.52

3.65

1.3

1.4

105.13

176.16

pmol/l

3.14

626

Calcific aortic valvular stenosis

626

0.52

3.65

1.3

1.4

105.13

176.16

pmol/l

3.14

626

Bleeding

288

2539

0.79

3.64

1.5

1.3

153.71

188.67

pmol/l

1.88

288

2539

Calcific aortic valvular stenosis, diagnosis (helper)

625

0.52

3.64

1.3

1.4

105.13

176.01

pmol/l

3.13

625

Operations 2 for CAVS

625

0.52

3.64

1.3

1.4

105.13

176.01

pmol/l

3.13

625

Extracorporeal dialysis

217

0.27

3.62

1.3

1.5

43.45

206.99

pmol/l

—

217

Erysipelas, including avohilmo

278

2594

0.79

3.59

1.4

1.3

182.46

187.43

pmol/l

0.05

278

2594

Generalized anxiety disorder

545

1.54

3.58

1.5

1.3

150.14

173.72

pmol/l

0.91

545

Diabetic nephropathy, excluding more controls

361

0.43

3.56

1.4

109.01

156.72

pmol/l

0.81

361

Type 1 diabetes, strict (exclude DM2)

561

0.49

3.54

1.2

1.3

176.67

191.44

pmol/l

0.28

561

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

198

1504

1.32

3.54

1.3

180.38

203.01

pmol/l

0.51

198

1504

Alzheimer disease

266

0.38

3.53

1.1

1.4

125.59

145.82

pmol/l

0.27

266

Diarrhoea and gastroenteritis of presumed infectious origin

370

2699

1.22

3.53

1.3

169.20

187.79

pmol/l

0.82

370

2699

Other congenital malformations of circulatory system

2.84

3.53

1.5

1.4

170.28

175.39

pmol/l

0.08

Caries of dentine, including avohilmo

280

1806

0.79

3.53

1.3

154.66

185.26

pmol/l

3.34

280

1806

Meniscus derangement

293

1542

1.26

3.52

1.4

1.3

193.51

195.97

pmol/l

0.02

293

1542

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

145

913

1.39

3.52

1.3

184.32

198.88

pmol/l

0.41

145

913

Persons with potential health hazards related to communicable diseases

204

1542

1.31

3.52

1.3

313.69

181.80

pmol/l

0.53

204

1542

Autoimmune diseases excluding thyroid diseases, strict definition

421

2764

0.83

3.50

1.3

158.63

182.51

pmol/l

3.21

421

2764

Alzheimer disease, including avohilmo

325

0.45

3.49

1.1

1.4

124.99

147.75

pmol/l

0.41

325

Cervical disc disorders

167

1240

1.35

3.48

1.2

1.3

153.70

169.51

pmol/l

0.99

167

1240

Ethmoidectomy

463

1.58

3.48

1.3

149.12

186.81

pmol/l

0.94

463

Combinations of oral blood glucose lowering drugs

1211

0.66

3.47

1.7

1.3

139.55

172.25

pmol/l

1.47

1211

Fissure and fistula of anal and rectal regions

123

869

1.42

3.47

1.4

1.3

169.31

184.21

pmol/l

0.48

123

869

Non-small cell lung cancer, including Hilmo

302

0.34

3.47

1.1

1.4

136.54

192.76

pmol/l

0.68

302

Alcohol abuse, main dg, excluding more controls

829

0.59

3.46

1.4

163.07

176.82

pmol/l

0.35

829

Other bacterial diseases, including avohilmo

387

2930

0.82

3.46

1.4

1.3

175.10

186.78

pmol/l

0.19

387

2930

Other disorders of fluid, electrolyte and acid-base balance

840

0.60

3.44

1.4

99.35

176.48

pmol/l

4.45

840

Any reimbursement code in KELA

288

1810

0.80

3.44

1.4

1.3

186.32

204.29

pmol/l

0.21

288

1810

Alcohol abuse, main dg

827

0.59

3.43

1.4

1.3

163.07

183.29

pmol/l

0.47

827

Mandibular retrognathia

159

2.02

3.42

1.3

1.4

200.65

229.16

pmol/l

0.19

159

Dilated cardiomyopathy

433

0.44

3.41

1.2

1.4

156.78

188.46

pmol/l

0.43

433

Cardiomyopathy

697

0.56

3.39

1.3

198.64

167.29

pmol/l

0.92

697

Other viral diseases, not elsewhere classified, including avohilmo

147

1070

1.37

3.36

1.3

153.43

186.08

pmol/l

1.82

147

1070

Sleep disorders, other/unspecified

2.33

3.34

1.3

152.39

167.03

pmol/l

0.22

Non-small cell lung cancer

205

0.29

3.34

1.0

1.4

136.02

202.46

pmol/l

—

205

Female infertility

2.65

3.32

1.2

1.1

10.58

22.52

pmol/l

0.79

Orthopaedic devices associated with adverse incidents

4.40

3.32

2.1

1.1

95.77

178.03

pmol/l

—

Arthrosis

372

1667

1.22

3.31

1.4

1.3

192.13

195.07

pmol/l

0.04

372

1667

Disorders of gallbladder, biliary tract and pancreas

310

2381

0.81

3.31

1.2

1.3

154.67

181.94

pmol/l

1.40

310

2381

Recurrent dislocation of patella

102

2.27

3.29

1.2

1.3

152.17

167.34

pmol/l

0.28

102

Migraine with aura and triptan purchases

233

1.81

3.28

1.5

1.3

131.62

138.74

pmol/l

0.15

233

Colorectal cancer, including Hilmo

703

0.58

3.27

1.2

1.4

166.46

178.68

pmol/l

0.29

703

Bacterial infection, other or unspecified, including avohilmo

167

1811

0.75

3.27

1.3

133.50

173.58

pmol/l

4.31

167

1811

Nonischemic cardiomyopathy

368

0.41

3.25

1.0

1.4

171.19

192.22

pmol/l

0.23

368

Emphysema

186

0.27

3.24

1.0

1.5

177.62

213.20

pmol/l

—

186

Atrial fibrillation and flutter with reimbursement

869

0.69

3.24

1.4

1.3

152.40

177.06

pmol/l

1.53

869

Chondromalacia

2.69

3.23

1.5

1.3

156.09

159.91

pmol/l

0.05

Acute and transient psychotic disorders

504

0.49

3.22

1.2

1.3

135.91

195.74

pmol/l

1.10

504

Hypertension, essential

321

2226

0.81

3.21

1.4

1.3

173.11

192.36

pmol/l

0.27

321

2226

ILD medications: immunosuppressive drugs

231

2645

0.79

3.20

1.3

151.15

192.12

pmol/l

2.95

231

2645

Diabetic maculopathy, excluding more controls

489

0.49

3.20

1.3

109.49

186.74

pmol/l

3.93

489

Candidiasis, including avohilmo

626

1.47

3.19

1.2

1.3

149.41

169.09

pmol/l

0.49

626

Autoimmune diseases excluding thyroid diseases

435

2810

0.84

3.19

1.3

157.62

182.29

pmol/l

3.48

435

2810

Other sleep disorders

334

1.65

3.15

1.2

1.3

162.64

175.62

pmol/l

0.34

334

Skin changes due to chronic exposure to nonionizing radiation

567

1.47

3.14

1.2

1.4

154.56

173.73

pmol/l

0.50

567

Propionic acid derivatives

128

458

1.41

3.13

1.3

1.2

175.10

194.14

pmol/l

1.09

128

458

Peripheral arterial reconstruction

362

0.41

3.13

1.5

1.4

105.20

184.04

pmol/l

1.65

362

FESS (DNB20)

446

1.55

3.07

1.4

1.3

151.36

187.16

pmol/l

0.82

446

Later onset COPD, excluding more controls

295

0.44

3.03

1.2

1.3

127.97

165.88

pmol/l

0.72

295

Other diseases of blood and blood-forming organs

203

1.83

3.03

1.7

1.4

157.36

161.21

pmol/l

0.05

203

Iron deficiency

3.35

3.02

1.2

1.3

201.25

130.91

pmol/l

0.47

Visual disturbances

192

1488

1.29

3.01

1.5

1.3

159.90

174.87

pmol/l

0.81

192

1488

Raynaud syndrome

189

1.86

3.01

1.5

1.4

142.18

210.99

pmol/l

0.74

189

Other enthesopathy of foot (+metatarsalgia)

189

1.86

3.00

1.5

1.3

164.92

160.69

pmol/l

0.08

189

Artificial joint operation, meniscal resection

450

2428

1.19

3.00

1.4

1.3

189.64

184.04

pmol/l

0.09

450

2428

Chronic apical periodontitis

436

2893

0.84

2.98

1.3

156.81

189.80

pmol/l

2.31

436

2893

Mild mental retardation

0.00

2.97

0.0

1.4

—

180.64

—

Use of biperiden

176

0.28

2.97

1.6

1.4

90.72

214.65

pmol/l

—

176

Other retinal disorders

173

1705

0.77

2.94

1.4

1.3

155.47

177.68

pmol/l

1.77

173

1705

Oxycodone

1111

0.70

2.94

1.3

102.32

171.02

pmol/l

7.65

1111

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

680

0.59

2.94

1.3

136.49

187.34

pmol/l

1.54

680

Actinic keratosis

541

1.46

2.93

1.2

1.4

154.86

175.05

pmol/l

0.51

541

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

499

0.52

2.91

1.3

1.4

140.05

185.08

pmol/l

0.80

499

Dental caries, including avohilmo

263

1669

0.81

2.90

1.3

157.36

184.36

pmol/l

2.50

263

1669

Follow-up examination after treatment for conditions other than malignant neoplasms

112

1030

0.72

2.90

1.2

1.3

145.39

178.47

pmol/l

2.71

112

1030

Diseases of the eye and adnexa

496

2114

1.18

2.90

1.4

1.3

173.09

184.23

pmol/l

0.96

496

2114

Ganglion

541

1.48

2.90

1.4

1.3

158.01

166.16

pmol/l

0.22

541

Substance abuse, excluding more controls

238

2474

0.80

2.88

1.4

1.3

159.25

189.80

pmol/l

1.55

238

2474

Anomalies of dental arch relationship, including avohilmo

570

1.45

2.88

1.3

192.27

191.34

pmol/l

0.01

570

Benign neoplasm: Skin of other and unspecified parts of face

192

1.83

2.87

1.3

1.5

133.25

208.90

pmol/l

0.88

192

Pain (limb, back, neck, head abdominally)

422

1777

1.19

2.85

1.5

1.3

199.87

196.70

pmol/l

0.04

422

1777

Other and unspecified disorders of skin and subcutaneous tissue

109

2.12

2.84

1.0

1.3

78.76

161.50

pmol/l

3.89

109

Torsion of testis

130

2.03

2.83

1.2

1.3

202.98

199.97

pmol/l

0.05

130

Melanocytic naevi

124

912

1.36

2.83

1.5

1.3

186.39

176.10

pmol/l

0.28

124

912

Impacted cerumen

245

1.72

2.82

1.6

1.4

162.26

206.23

pmol/l

0.49

245

therapeutic use

2.79

2.82

1.8

1.2

97.22

157.73

pmol/l

1.65

Rotator cuff syndrome

295

1660

1.22

2.81

1.4

1.3

146.63

187.74

pmol/l

1.81

295

1660

Donors of organs and tissues

2.68

2.81

1.6

1.4

153.77

177.72

pmol/l

0.27

Gout, idiopatic and unspecified

929

0.65

2.81

1.6

1.3

137.40

172.01

pmol/l

1.49

929

Mesial bite

3.98

2.79

1.4

1.1

149.74

173.19

pmol/l

—

Substance use, excluding alcohol

1165

0.69

2.79

1.2

1.3

140.12

191.00

pmol/l

2.30

1165

Hernia of abdominal wall

227

1819

1.25

2.75

1.4

1.3

159.58

172.47

pmol/l

0.66

227

1819

Hypertensive diseases

336

2275

0.83

2.75

1.5

1.3

170.29

193.33

pmol/l

0.36

336

2275

Oligomenorrhoea

8.35

2.75

1.4

1.0

16.68

13.52

pmol/l

—

Hypertension

336

2274

0.83

2.74

1.5

1.3

170.29

193.33

pmol/l

0.36

336

2274

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

338

2729

0.83

2.73

1.3

156.11

187.45

pmol/l

2.06

338

2729

Early syphilis

2.64

2.73

1.4

1.5

196.17

166.12

pmol/l

0.71

Congenital ptosis, including avohilmo

6.19

2.72

1.0

2.1

256.67

185.36

pmol/l

—

Other disorders of ear

425

2328

1.18

2.72

1.4

1.3

157.98

176.40

pmol/l

2.12

425

2328

Alcoholic liver disease

434

0.50

2.72

1.4

1.3

133.99

190.05

pmol/l

1.22

434

Hypertrophy of (infrapatellar) fat pad

3.51

2.71

1.9

1.3

258.20

167.82

pmol/l

—

Paracetamol or NSAID medication

333

1.44

2.70

1.3

1.2

179.74

199.97

pmol/l

0.99

333

Gout, FINNGEN

1068

0.69

2.69

1.7

1.4

139.85

174.26

pmol/l

1.77

1068

Dislocation, sprain and strain of joints and ligaments at neck level

559

1.45

2.68

1.3

1.4

178.38

185.33

pmol/l

0.12

559

Presbyopia

249

1.70

2.68

1.2

1.4

214.38

198.48

pmol/l

0.10

249

Cystitis

174

1328

0.78

2.68

1.4

1.3

142.97

169.46

pmol/l

1.42

174

1328

Excessive earwax

289

2156

1.22

2.68

1.5

1.3

205.83

174.30

pmol/l

0.47

289

2156

Symptoms and signs involving the skin and subcutaneous tissue

298

2325

1.21

2.67

1.3

160.98

185.26

pmol/l

1.00

298

2325

Disorders of ocular muscles, binocular movement, accommodation and refraction

217

1721

1.25

2.67

1.3

178.07

180.32

pmol/l

0.07

217

1721

Other sexually transmitted chlamydial diseases, including avohilmo

462

1.50

2.67

1.3

219.47

202.86

pmol/l

0.29

462

Pollen allergy

658

1.41

2.67

1.2

1.4

180.22

193.32

pmol/l

0.30

658

Fibrosis and cirrhosis of liver

199

0.35

2.66

1.0

1.5

203.13

211.92

pmol/l

—

199

Other CVD (FINNGEN)

330

0.51

2.65

1.2

1.3

159.00

178.55

pmol/l

0.40

330

Glomerular diseases

647

0.60

2.64

1.5

1.3

148.55

184.41

pmol/l

0.99

647

Cough

147

1046

1.31

2.63

1.3

174.49

175.95

pmol/l

0.03

147

1046

Insulin, fast-acting (human)

720

0.62

2.62

1.3

1.4

166.50

197.82

pmol/l

0.86

720

Allergic asthma (mode)

117

843

1.36

2.62

1.3

176.28

199.94

pmol/l

0.86

117

843

Pneumonias (Asthma/COPD co-morbidities)

398

3054

0.85

2.61

1.4

1.3

158.52

188.63

pmol/l

2.00

398

3054

Colorectal cancer

631

0.61

2.61

1.2

1.4

163.84

180.33

pmol/l

0.39

631

Other noninflammatory disorders of vulva and perineum

4.67

2.59

1.0

8.81

14.36

pmol/l

—

Metatarsalgia

163

1.85

2.57

1.4

1.3

168.67

161.20

pmol/l

0.12

163

Panhypopituitarism

2.76

2.55

1.5

37.51

184.88

pmol/l

10.64

Open wound of head

235

2705

0.81

2.55

1.4

1.3

178.79

190.20

pmol/l

0.41

235

2705

Sequelae of cerebrovascular disease

879

0.69

2.55

1.4

127.09

173.65

pmol/l

2.40

879

Type 1 diabetes, strict definition

487

0.55

2.55

1.2

1.3

182.67

192.25

pmol/l

0.17

487

Allergic asthma (mode), excluding more controls

117

848

1.35

2.54

1.3

176.28

199.71

pmol/l

0.86

117

848

Pneumonitis due to solids and liquids

209

0.38

2.53

1.3

1.4

94.33

206.82

pmol/l

—

209

Abdominal and pelvic pain

574

2510

1.15

2.53

1.4

1.3

170.18

192.48

pmol/l

1.19

574

2510

Amputation

259

0.38

2.52

1.4

98.41

201.61

pmol/l

—

259

Glomerular disorders in diseases classified elsewhere

422

0.52

2.51

1.6

1.4

128.45

192.93

pmol/l

1.44

422

Impacted maxillary molar

172

1.81

2.50

1.2

1.3

182.33

170.64

pmol/l

0.15

172

Blepharochalasis

428

1.50

2.50

1.2

1.3

132.08

181.58

pmol/l

1.35

428

Fever of other and unknown origin

188

2040

0.80

2.49

1.3

157.23

189.39

pmol/l

1.39

188

2040

Non-seminoma of testis, including Hilmo

2.64

2.49

1.2

1.5

131.10

205.19

pmol/l

0.80

Colonic or urogenital fistula

125

942

1.33

2.48

1.4

168.16

178.81

pmol/l

0.33

125

942

Any operation in hilmo

138

1.68

2.47

1.5

1.2

190.25

200.38

pmol/l

0.25

138

Benign paroxysmal vertigo

544

1.44

2.47

1.3

1.4

172.35

174.06

pmol/l

0.03

544

646

1.38

2.47

1.2

1.4

158.62

173.52

pmol/l

0.37

646

Amenorrhoea

3.82

2.46

1.0

11.86

16.17

pmol/l

—

Transient global amnesia

137

1.90

2.45

1.2

1.4

164.44

159.34

pmol/l

0.08

137

All pneumoniae

403

3052

0.86

2.42

1.4

1.3

160.25

188.31

pmol/l

1.80

403

3052

Other inflammation of eyelid

319

1.57

2.42

1.4

159.39

188.13

pmol/l

0.40

319

Unspecified/other endometriosis

3.39

2.42

1.0

9.89

14.05

pmol/l

—

Other cataract

102

1026

0.74

2.42

1.4

1.3

149.52

175.75

pmol/l

1.12

102

1026

Diabetic nephropathy

372

0.50

2.41

1.4

109.01

154.35

pmol/l

0.77

372

Seborrhoeic keratosis

522

1.44

2.41

1.4

1.3

191.43

178.57

pmol/l

0.26

522

Car occupant injured in other and unspecified transport accidents

100

733

1.37

2.40

1.4

165.52

187.35

pmol/l

0.69

100

733

Procedures for purposes other than remedying health state

3.35

2.39

1.1

1.2

174.24

160.20

pmol/l

—

Fracture of femur

490

0.59

2.39

1.3

1.4

200.14

181.34

pmol/l

0.31

490

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

444

2984

1.16

2.37

1.4

1.3

166.99

186.49

pmol/l

1.15

444

2984

Alzheimer disease, excluding more controls

191

0.44

2.35

1.2

1.4

135.12

173.66

pmol/l

0.57

191

Diseases of pulp and periapical tissues, including avohilmo

413

2483

0.86

2.33

1.3

153.60

194.93

pmol/l

3.02

413

2483

Persistent delusional disorders

262

0.42

2.31

1.4

177.45

196.40

pmol/l

0.15

262

Early syphilis, including avohilmo

2.41

2.31

1.4

196.17

165.48

pmol/l

0.73

Lung diseases due to external agents

344

0.49

2.31

1.4

108.04

190.47

pmol/l

1.68

344

Caries of dentine

1060

0.72

2.31

1.4

1.3

126.75

183.13

pmol/l

4.76

1060

Malignant neoplasm of eye, brain and central nervous system, including Hilmo

216

0.41

2.30

1.3

1.4

112.34

209.83

pmol/l

—

216

Other shoulder lesions

284

1.59

2.30

1.5

1.3

137.15

165.82

pmol/l

1.07

284

Obesity related asthma

155

1217

1.28

2.30

1.4

1.3

148.95

176.34

pmol/l

1.69

155

1217

Other symptoms and signs involving the digestive system and abdomen

222

1.67

2.30

1.5

1.3

204.25

195.24

pmol/l

0.07

222

Gout, strict definition

647

0.63

2.29

1.7

1.3

134.86

178.99

pmol/l

1.35

647

Cervicobrachial syndrome

603

1.40

2.29

1.2

1.3

155.62

166.26

pmol/l

0.33

603

Macular pucker

269

1.60

2.28

1.4

1.3

167.47

185.56

pmol/l

0.21

269

Hallux rigidus

238

1.64

2.28

1.5

1.3

147.71

177.22

pmol/l

1.05

238

Cardiac arrest

268

0.47

2.27

1.2

1.3

223.30

179.94

pmol/l

1.09

268

Pedal cyclist injured in collision with motor vehicle

2.08

2.27

1.2

1.4

167.49

168.01

pmol/l

0.01

Hyperfunction of pituitary gland

2.23

2.27

1.4

1.3

123.61

172.03

pmol/l

0.98

Vulvovaginal ulceration/inflammation in other diseases

3.48

2.27

1.0

1.2

5.50

14.89

pmol/l

—

Malignant neoplasm of eye, brain and central nervous system

157

0.32

2.26

1.2

1.4

97.46

222.76

pmol/l

—

157

Colorectal adenocarcinoma

539

0.60

2.26

1.2

1.4

164.41

182.79

pmol/l

0.37

539

Other salmonella infections, including avohilmo

113

1.96

2.25

1.7

1.3

142.10

160.49

pmol/l

0.28

113

Polycystic kidney disease

0.00

2.25

0.0

1.2

—

168.62

—

Unspecified acute lower respiratory infection

728

0.66

2.25

1.2

1.3

175.16

185.00

pmol/l

0.20

728

Dental caries

1141

0.73

2.24

1.3

136.52

181.78

pmol/l

3.49

1141

Chronic pancreatitis

532

0.60

2.24

1.1

1.4

204.99

186.95

pmol/l

0.25

532

Benign thyroid growths and nodules

324

1.52

2.24

1.2

1.4

150.12

179.97

pmol/l

0.46

324

Neurological diseases, wide definition

178

708

1.26

2.22

1.4

1.2

219.11

204.26

pmol/l

0.11

178

708

Type 1 diabetes, strict definition, subgroup 1

466

0.57

2.22

1.2

1.3

182.67

191.60

pmol/l

0.16

466

Complications of surgical and medical care, not elsewhere classified

353

2749

0.86

2.20

1.4

1.3

153.63

185.51

pmol/l

1.86

353

2749

AV-block

421

0.59

2.19

1.7

1.4

181.91

164.46

pmol/l

0.30

421

Diaphragmatic hernia

107

805

1.33

2.19

1.3

1.4

157.12

176.10

pmol/l

0.68

107

805

Thyroiditis

2.13

2.18

1.8

1.3

136.61

146.87

pmol/l

0.14

Gout, unspecified

735

0.66

2.18

1.6

1.3

141.62

177.21

pmol/l

1.22

735

Pruritus

158

1.78

2.17

1.3

1.4

134.46

211.33

pmol/l

0.66

158

Other viral diseases, including avohilmo

206

1667

1.23

2.16

1.3

156.18

200.08

pmol/l

1.76

206

1667

Neurotic, stress-related and somatoform disorders

458

2749

1.15

2.16

1.4

1.3

181.93

188.02

pmol/l

0.10

458

2749

Other disorders of eyelid

112

801

1.32

2.16

1.4

1.3

162.19

171.31

pmol/l

0.24

112

801

Other and unspecified disorders of vitreous body

115

857

1.31

2.15

1.3

398.92

168.73

pmol/l

0.51

115

857

Respiratory insufficiency

165

0.36

2.14

1.5

1.3

79.55

227.17

pmol/l

—

165

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

251

1041

1.21

2.13

1.4

1.3

198.82

194.50

pmol/l

0.04

251

1041

Spirochaetal infections, other/unspecified

197

1.68

2.11

1.2

1.4

147.25

204.98

pmol/l

0.61

197

Follow-up care involving plastic surgery

2.46

2.10

1.2

76.78

140.17

pmol/l

1.41

Abnormal spermatozoa

514

1.41

2.07

1.5

1.4

144.11

184.96

pmol/l

1.11

514

Gastrointestinal diseases

322

1369

1.18

2.07

1.3

167.36

193.25

pmol/l

2.09

322

1369

Conjunctivitis

342

2360

1.17

2.07

1.3

177.53

192.01

pmol/l

0.56

342

2360

Acute pharyngitis

105

788

1.32

2.07

1.3

174.07

191.10

pmol/l

0.54

105

788

Alzheimer’s disease, strict definition

202

0.44

2.06

1.1

1.4

150.41

142.27

pmol/l

0.08

202

Anxiety disorders

460

2761

1.14

2.06

1.4

1.3

182.30

188.22

pmol/l

0.10

460

2761

Vasomotor rhinitis (mode)

146

1.79

2.06

1.3

1.4

126.52

157.39

pmol/l

0.74

146

Calcaneal spur

3.53

2.06

1.6

1.2

194.43

168.83

pmol/l

—

Malignant neoplasm of colon, including Hilmo

443

0.58

2.06

1.2

1.4

139.00

188.23

pmol/l

1.13

443

Valvular operations

556

0.63

2.06

1.3

163.47

167.55

pmol/l

0.06

556

Persons encountering health services for examination and investigation

371

1599

1.16

2.04

1.4

1.3

195.58

200.39

pmol/l

0.06

371

1599

Mood [affective] disorders

516

2914

1.13

2.04

1.4

1.3

159.05

189.27

pmol/l

2.14

516

2914

Visual disturbances and blindness

194

1586

1.22

2.04

1.5

1.3

159.35

174.39

pmol/l

0.85

194

1586

Acute tubulo-interstitial nephritis

124

1339

0.78

2.03

1.4

1.3

139.78

165.93

pmol/l

1.44

124

1339

Glucosamine medication

572

1.34

2.03

1.3

1.4

155.15

178.28

pmol/l

0.60

572

Gout

873

0.73

2.03

1.7

1.3

139.85

172.33

pmol/l

2.19

873

Complications of internal orthopaedic prosthetic devices, implants and grafts

449

1.43

2.02

1.4

130.67

186.42

pmol/l

1.55

449

Rubella [German measles]

271

1.57

2.02

1.2

1.3

166.61

188.58

pmol/l

0.23

271

Rubella [German measles], including avohilmo

271

1.57

2.02

1.2

1.3

166.61

188.58

pmol/l

0.23

271

Other specified/unspecified bacterial intestinal infections

147

1.78

2.02

1.4

1.3

146.15

220.75

pmol/l

0.60

147

Diseases of pulp and periapical tissues and dental caries

244

1498

0.83

2.02

1.4

1.3

159.46

187.20

pmol/l

2.26

244

1498

Asthma and allergy

436

1.43

2.00

1.3

179.97

207.13

pmol/l

0.52

436

Secondary hypertension

359

0.55

2.00

1.6

1.3

118.16

180.23

pmol/l

2.01

359

Mood disorders

516

2914

1.13

1.99

1.4

1.3

159.05

189.27

pmol/l

2.14

516

2914

Family history of certain disabilities and chronic diseases leading to disablement

126

1.83

1.98

1.6

1.3

181.21

169.59

pmol/l

0.16

126

Disorders of acoustic nerve

2.30

1.98

1.5

1.4

169.16

165.15

pmol/l

0.04

Gonarthrosis

287

1371

1.18

1.97

1.4

1.3

186.14

175.18

pmol/l

0.13

287

1371

Disorders of lens

214

1600

0.83

1.97

1.3

142.15

174.49

pmol/l

3.29

214

1600

Sudden idiopathic hearing loss

256

1.57

1.97

1.5

1.4

146.36

199.85

pmol/l

0.76

256

Stenosis and insufficiency of lacrimal passages

119

1.85

1.96

1.3

1.4

159.26

222.96

pmol/l

0.37

119

Other articular cartilage disorders

2.37

1.95

1.8

1.3

146.47

182.70

pmol/l

0.73

Benign neoplasm: Pituitary gland, craniopharyngeal duct

134

1.80

1.95

1.7

1.4

112.13

159.93

pmol/l

1.31

134

Blepharospasm

4.59

1.94

1.0

1.1

195.38

182.07

pmol/l

—

Spermatocele

346

1.48

1.94

1.5

1.3

188.34

188.39

pmol/l

0.00

346

Asthma and allergy, excluding more controls

439

1.42

1.94

1.3

179.97

206.68

pmol/l

0.51

439

Nontoxic goitre/thyroid nodule

265

1.55

1.94

1.2

1.4

154.02

178.90

pmol/l

0.29

265

Diseases of external ear

151

1211

1.25

1.93

1.6

1.3

147.11

178.08

pmol/l

1.75

151

1211

Idiopathic gout

321

0.53

1.92

1.9

1.4

124.54

199.27

pmol/l

1.38

321

Undetermined asthma

330

1.49

1.92

1.3

158.73

199.53

pmol/l

0.68

330

Benign neoplasm of male genital organs

2.07

1.92

1.7

1.4

113.16

166.56

pmol/l

1.41

Retinal detachments and breaks

128

1008

1.27

1.92

1.3

1.4

158.08

171.59

pmol/l

0.50

128

1008

Neoplasms

495

2292

1.13

1.90

1.4

1.3

171.96

197.25

pmol/l

1.24

495

2292

Hyperlipidaemia, other/unspecified

108

1250

0.78

1.90

1.3

155.66

178.48

pmol/l

1.26

108

1250

Pectus excavatum

3.26

1.90

1.1

1.2

168.33

219.34

pmol/l

—

Other and unspecified mental retardation

0.00

1.89

0.0

1.4

—

190.60

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

173

1335

0.82

1.89

1.3

227.58

196.55

pmol/l

0.23

173

1335

Tramadol

384

2007

1.15

1.89

1.4

1.3

182.17

190.08

pmol/l

0.11

384

2007

Male infertility

491

1.40

1.89

1.5

1.3

190.48

214.42

pmol/l

0.43

491

COPD-related respiratory insufficiency

253

0.47

1.88

1.3

1.4

123.54

190.65

pmol/l

0.83

253

Other and unspecified nerve root and plexus disorders, also in other diseases

106

817

1.30

1.88

1.4

1.3

153.96

180.14

pmol/l

0.98

106

817

Chronic viral hepatitis

305

0.52

1.88

1.2

1.4

169.06

203.62

pmol/l

0.31

305

Bacterial, viral and other infectious agents, including avohilmo

474

1.40

1.87

1.3

1.4

165.65

191.97

pmol/l

0.57

474

Amputation of ankle bones

0.00

1.87

0.0

1.4

—

150.36

—

Motorcycle rider injured in noncollision transport accidents

174

1.68

1.87

1.2

1.4

166.62

221.38

pmol/l

0.49

174

Recurrent dislocation and subluxation of joint

268

1.54

1.86

1.4

1.3

150.93

181.85

pmol/l

0.93

268

Other disorders of adrenal gland

2.09

1.86

1.1

1.4

85.89

171.17

pmol/l

1.90

Other specified/unspecified inflammatory spondylopathies

129

1.79

1.85

1.3

163.62

158.85

pmol/l

0.08

129

Type1 diabetes, definitions combined, early onset

341

0.55

1.85

1.2

1.4

198.03

190.91

pmol/l

0.10

341

Myocardial infarction, unclassifiable

408

0.61

1.85

1.5

1.4

109.25

181.73

pmol/l

2.17

408

Alzheimer’s disease (Late onset)

166

0.45

1.85

1.0

1.3

158.88

139.74

pmol/l

—

166

Adverse effects, not elsewhere classified

483

1.39

1.85

1.3

124.04

180.09

pmol/l

1.88

483

Unspecified kidney failure

237

0.46

1.84

1.2

1.4

169.35

204.10

pmol/l

0.27

237

Lateral epicondylitis

442

1.41

1.83

1.4

1.3

160.10

168.51

pmol/l

0.23

442

Problems related to lifestyle

515

0.64

1.83

1.2

1.3

135.49

173.83

pmol/l

1.17

515

Other diseases of the respiratory system

490

0.63

1.81

1.4

117.80

178.77

pmol/l

1.84

490

Other respiratory disorders and diseases

490

0.63

1.81

1.4

117.80

178.77

pmol/l

1.84

490

Ulcer of lower limb, not elsewhere classified

403

0.59

1.81

1.5

1.4

121.58

187.96

pmol/l

1.54

403

Disturbances of smell and taste

2.06

1.80

1.4

1.3

203.67

165.55

pmol/l

0.67

Other systemic involvement of connective tissue

385

1.43

1.79

1.3

1.4

131.95

175.19

pmol/l

0.93

385

Pediculosis, acariasis and other infestations

274

0.51

1.79

1.9

1.4

158.59

201.49

pmol/l

0.45

274

Sequelae of other external causes

138

1.75

1.79

1.4

196.38

163.95

pmol/l

0.60

138

Femoral hernia, unilateral

2.77

1.79

1.3

1.2

178.44

163.27

pmol/l

—

Inguinal of femoral hernia, unilateral

2.77

1.79

1.3

1.2

178.44

163.27

pmol/l

—

Inguinal hernia, unilateral

2.77

1.79

1.3

1.2

178.44

163.27

pmol/l

—

Other pulmonary diagnosis

410

1799

1.14

1.78

1.4

1.3

161.99

184.60

pmol/l

2.36

410

1799

Localized swelling, mass and lump of skin and subcutaneous tissue

124

983

1.26

1.78

1.3

1.4

174.37

177.44

pmol/l

0.06

124

983

Klinefelter syndrome, karyotype 47 XXY

3.51

1.78

1.0

1.7

147.15

232.58

pmol/l

—

Other protozoal intestinal diseases, including avohilmo

2.36

1.78

1.6

1.4

207.09

182.28

pmol/l

0.37

Ill-defined and unknown causes of mortality

220

0.45

1.78

1.2

1.5

168.82

166.93

pmol/l

—

220

Hyperprolactinaemia

2.35

1.78

1.4

107.00

162.09

pmol/l

1.06

Sacroiliitis, not elsewhere classified

146

1.72

1.77

1.1

1.3

185.44

167.12

pmol/l

0.29

146

Diseases of liver

105

1341

0.78

1.77

1.4

1.3

139.32

177.78

pmol/l

2.53

105

1341

Ovarian cyst

2.08

1.76

1.0

1.1

8.29

22.05

pmol/l

0.98

Small fibre neuropathy

2.10

1.76

1.4

1.3

138.06

156.49

pmol/l

0.24

Other diseases of gallbladder

2.10

1.76

1.6

1.3

141.49

145.53

pmol/l

0.04

Patellar tendinitis

1.95

1.76

1.4

1.3

194.42

173.31

pmol/l

0.25

Other sex chromosome abnormalities, male phenotype, not elsewhere classified

2.77

1.75

1.1

1.5

165.86

221.12

pmol/l

—

Thoracic aortic aneurysm

600

1.34

1.75

1.2

1.4

144.29

180.20

pmol/l

1.24

600

Transplanted organ and tissue status

411

0.61

1.75

1.7

1.4

90.17

171.83

pmol/l

3.45

411

Dystonia

1.98

1.74

1.6

1.5

179.86

148.76

pmol/l

0.78

Female genital prolapse

3.71

1.74

1.2

1.0

20.17

9.34

pmol/l

—

Disturbances of skin sensation

107

836

1.28

1.74

1.4

1.3

151.04

174.73

pmol/l

0.85

107

836

Pectus excavatum, including avohilmo

2.98

1.73

1.1

1.2

168.33

222.27

pmol/l

—

Congenital malformations of eye, ear, face and neck

170

1.65

1.73

1.3

187.41

224.47

pmol/l

0.28

170

Undetermined asthma, excluding more controls

338

1.45

1.73

1.3

1.2

158.73

199.14

pmol/l

0.68

338

Benign neoplasm: Skin of eyelid, including canthus

273

1.50

1.73

1.4

139.64

199.37

pmol/l

0.98

273

Open bite

110

1.82

1.73

1.1

1.2

241.56

170.71

pmol/l

0.35

110

Postzoster neuralgia

2.94

1.72

1.4

1.2

132.73

167.97

pmol/l

—

Female infertility, associated with anovulation

2.67

1.72

1.1

11.36

14.63

pmol/l

—

Other and unspecified disorders of pigmentation

3.89

1.72

1.2

176.18

187.95

pmol/l

—

Malignant neoplasm of testis, including Hilmo

133

1.75

1.71

1.3

1.4

136.55

187.57

pmol/l

0.94

133

Bacterial, viral and other infectious agents

457

1.38

1.71

1.3

1.4

163.14

191.28

pmol/l

0.60

457

Persistent mood disorders

559

1.34

1.71

1.3

139.91

185.04

pmol/l

1.42

559

Disorders of choroid and retina

277

2251

0.86

1.71

1.4

1.3

160.28

176.01

pmol/l

1.41

277

2251

Nontraumatic intracranial haemmorrhage

482

0.64

1.71

1.5

1.4

142.40

181.41

pmol/l

0.98

482

Other soft tissue disorders, not elsewhere classified

458

2309

1.13

1.70

1.3

163.05

190.67

pmol/l

0.62

458

2309

Thyrotoxicosis with toxic multinodular goitre

2.30

1.70

1.1

1.2

120.32

139.00

pmol/l

0.23

Diseases of salivary glands

120

954

1.26

1.70

1.2

1.3

165.95

176.12

pmol/l

0.33

120

954

Nontoxic single thyroid nodule

2.06

1.70

1.1

1.2

180.42

147.89

pmol/l

0.47

ILD medications: azathioprine

601

0.68

1.70

1.4

161.60

195.42

pmol/l

0.87

601

Spondylopathies (FG)

543

1.35

1.69

1.2

1.3

167.70

177.92

pmol/l

0.35

543

Inguinal hernia

423

2485

1.13

1.69

1.3

1.4

238.14

182.63

pmol/l

0.44

423

2485

Nasal polyp

699

1.30

1.69

1.3

450.06

185.29

pmol/l

0.45

699

Amputation of toe

178

0.45

1.69

1.4

122.10

212.72

pmol/l

—

178

Psychiatric diseases

495

2208

1.12

1.68

1.3

181.73

180.10

pmol/l

0.03

495

2208

Other skin changes

433

1.39

1.67

1.3

1.4

139.77

180.45

pmol/l

0.97

433

Depression

482

2873

1.12

1.67

1.3

156.79

189.72

pmol/l

2.40

482

2873

Alzheimer’s disease (Late onset), excluding more controls

124

0.47

1.67

1.0

1.5

158.88

166.71

pmol/l

—

124

Malignant neoplasm of brain, including Hilmo

161

0.43

1.67

1.4

99.20

221.18

pmol/l

—

161

General examination and investigation of persons without complaint and reported diagnosis

353

1599

1.15

1.66

1.4

1.3

185.21

200.39

pmol/l

0.20

353

1599

Other protozoal intestinal diseases

2.60

1.66

1.9

1.5

188.88

181.38

pmol/l

—

Anxiety disorders, excluding more controls

425

2403

1.13

1.66

1.4

1.3

183.62

189.85

pmol/l

0.10

425

2403

Mental and behavioural disorders due to sedatives or hypnotics

317

0.57

1.65

1.3

1.4

135.67

204.19

pmol/l

0.96

317

Hypertensive diseases (excluding secondary)

250

1699

0.85

1.65

1.5

1.3

180.61

200.39

pmol/l

0.21

250

1699

Other functional intestinal disorders

149

1105

1.23

1.65

1.4

1.3

153.41

180.65

pmol/l

1.37

149

1105

Hard cardiovascular diseases

331

2238

0.87

1.65

1.4

1.3

158.26

189.44

pmol/l

1.61

331

2238

Other salmonella infections

2.04

1.64

2.1

1.3

87.36

156.35

pmol/l

2.23

Other congenital malformations of face and neck

1.99

1.64

1.5

168.25

174.03

pmol/l

0.06

Myocardial infarction, with ST-elevation

525

0.67

1.64

1.2

1.4

159.31

177.63

pmol/l

0.30

525

Paroxysmal tachycardia

785

0.75

1.64

1.4

1.3

167.33

177.96

pmol/l

0.38

785

Azathioprine

596

0.69

1.64

1.4

161.60

193.60

pmol/l

0.80

596

Epilepsy

1042

0.76

1.63

1.2

1.3

171.14

187.20

pmol/l

0.28

1042

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

310

1.46

1.63

1.4

1.3

150.23

182.81

pmol/l

1.12

310

Other diseases of pleura

110

1201

0.79

1.63

1.3

151.50

172.75

pmol/l

0.88

110

1201

Deforming dorsopathies

101

791

1.28

1.62

1.5

1.3

160.00

171.29

pmol/l

0.54

101

791

Hypermetropia

181

1.61

1.62

1.4

191.69

216.32

pmol/l

0.19

181

Recurrent aphthous stomatitis , including avohilmo

352

1.42

1.61

1.4

163.90

192.22

pmol/l

0.45

352

Senile cataract

180

1311

0.83

1.61

1.3

138.61

173.94

pmol/l

3.14

180

1311

Benign neoplasm: Cranial nerves

2.16

1.61

1.6

1.3

157.17

170.36

pmol/l

0.16

Non-seminoma of testis

3.12

1.60

1.3

1.6

84.68

216.06

pmol/l

—

Other ill-defined and unspecified causes of mortality

190

0.47

1.60

1.1

1.5

179.80

162.04

pmol/l

—

190

Diseases of appendix

373

2943

1.13

1.60

1.4

1.3

173.64

184.26

pmol/l

0.48

373

2943

Enthesopathies of lower limb, excluding foot

758

1.28

1.60

1.4

1.3

268.92

167.64

pmol/l

0.55

758

Other viral hepatitis, including avohilmo

376

0.61

1.60

1.2

1.4

157.07

201.81

pmol/l

0.59

376

Appendicitis, broad definition

371

2938

1.13

1.59

1.4

1.3

173.38

184.33

pmol/l

0.49

371

2938

Urethritis and urethral syndrome

2.34

1.59

1.5

1.2

197.67

174.31

pmol/l

—

Dorsalgia

492

2331

1.12

1.59

1.5

1.3

193.47

190.19

pmol/l

0.05

492

2331

Congenital malformations of eyelid, lacrimal apparatus and orbit, including avohilmo

3.03

1.58

1.0

1.6

256.67

190.84

pmol/l

—

Ehlers-Danlos syndrome, including avohilmo

3.02

1.58

1.7

1.1

53.45

184.65

pmol/l

—

Abnormal findings on diagnostic imaging of central nervous system

121

1.74

1.58

1.2

1.4

172.08

166.36

pmol/l

0.07

121

Polymyalgia rheumatica

167

1.62

1.57

1.3

1.4

138.22

208.60

pmol/l

0.65

167

Other diseases of lip and oral mucosa

158

1307

1.21

1.57

1.3

157.09

175.93

pmol/l

0.97

158

1307

Malignant neoplasm of pancreas, including Hilmo

173

0.46

1.57

1.0

1.4

135.66

167.78

pmol/l

—

173

Malignant neoplasm of colon

350

0.60

1.57

1.2

1.4

141.76

193.35

pmol/l

0.88

350

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

470

0.66

1.55

1.2

1.3

131.35

207.10

pmol/l

1.34

470

Malignant neoplasm of rectum

273

0.55

1.55

1.2

1.4

190.03

203.19

pmol/l

0.14

273

Examination and encounter for administrative purposes

264

1.48

1.55

1.3

1.4

173.45

167.87

pmol/l

0.14

264

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

139

0.44

1.55

1.0

1.1

9.34

25.75

pmol/l

—

139

Other systemic involvement of connective tissue (FG)

365

1.40

1.54

1.4

1.3

126.45

156.95

pmol/l

1.39

365

Atopic conjunctivitis

107

1.78

1.54

1.9

1.3

174.75

163.04

pmol/l

0.17

107

Benign neoplasm: Sigmoid colon

483

1.35

1.54

1.3

168.59

181.07

pmol/l

0.22

483

Fasciculation

2.45

1.54

1.6

1.2

165.00

180.22

pmol/l

—

Benign neoplasm: Other and unspecified parts of mouth

2.04

1.54

1.0

1.2

168.09

172.45

pmol/l

0.06

Wide developmental disorders, excluding more controls

134

1.69

1.54

1.1

1.4

99.87

191.91

pmol/l

2.64

134

Focal epilepsy

727

0.73

1.53

1.2

1.3

194.86

184.41

pmol/l

0.10

727

Pure hypercholesterolaemia

294

2139

0.87

1.53

1.4

1.3

154.05

188.54

pmol/l

1.77

294

2139

Acute appendicitis

354

2901

1.13

1.53

1.4

1.3

171.98

184.51

pmol/l

0.58

354

2901

Bipolar affective disorders

746

1.28

1.53

1.3

150.97

185.76

pmol/l

1.06

746

Ehlers-Danlos syndrome

3.36

1.53

1.8

1.1

62.54

197.52

pmol/l

—

Cholelithiasis, broad definition with cholecystitis

230

1784

0.86

1.52

1.3

150.52

168.15

pmol/l

1.28

230

1784

Persons encountering health services in circumstances related to reproduction

388

2306

1.13

1.52

1.4

1.3

186.08

196.47

pmol/l

0.35

388

2306

Mood disorders, excluding more controls

473

2490

1.12

1.52

1.3

160.68

189.17

pmol/l

1.69

473

2490

Use of memantine

219

0.55

1.52

1.1

1.4

95.03

147.98

pmol/l

1.30

219

Use of other anti-dementia drugs

219

0.55

1.52

1.1

1.4

95.03

147.98

pmol/l

1.30

219

Excluding asthma or asthma-COPD overlap

405

1799

1.13

1.51

1.4

1.3

163.43

184.60

pmol/l

2.12

405

1799

Obsessive-compulsive disorder

241

1.50

1.51

1.3

177.63

178.93

pmol/l

0.02

241

Use of rivastigmine

141

0.42

1.51

1.2

1.3

114.82

149.76

pmol/l

—

141

Other misadventures during surgical and medical care

2.17

1.51

1.8

1.2

139.74

161.45

pmol/l

0.27

Astigmatism

177

1.59

1.50

1.5

1.4

160.59

220.71

pmol/l

0.55

177

All anxiety disorders

332

2266

1.14

1.50

1.4

1.3

163.92

194.38

pmol/l

1.61

332

2266

Metabolic disorders

384

2592

0.89

1.50

1.4

1.3

153.52

190.19

pmol/l

2.51

384

2592

Disorders of vestibular function (Vertigo)

131

1041

1.23

1.50

1.3

1.4

162.36

170.50

pmol/l

0.26

131

1041

Foreign body on external eye

1086

0.78

1.50

1.4

1.3

165.17

188.11

pmol/l

1.01

1086

Cramp and spasm

131

1.69

1.49

1.7

1.4

164.19

229.42

pmol/l

0.41

131

Other erythematous conditions

2.08

1.49

1.2

1.4

156.38

171.15

pmol/l

0.16

Anxiety (asthma-related co-morbidities)

328

2193

1.14

1.49

1.4

1.3

164.74

198.09

pmol/l

1.67

328

2193

Hernia of abdominal wall, postoperative

656

1.29

1.48

1.2

1.3

164.70

194.75

pmol/l

0.74

656

Pyogenic granuloma

2.45

1.48

1.3

1.5

184.76

185.50

pmol/l

—

Asthma/COPD (KELA code 203)

391

2931

0.89

1.48

1.3

165.63

188.18

pmol/l

1.35

391

2931

Heterophoria

186

1.56

1.48

1.1

1.4

134.25

158.27

pmol/l

0.55

186

Other disorders of bladder

342

1.41

1.48

1.2

1.4

149.84

193.52

pmol/l

0.82

342

Disorders of lipoprotein metabolism and other lipidaemias

338

2327

0.88

1.48

1.4

1.3

155.13

189.52

pmol/l

1.99

338

2327

Single spontaneous delivery

0.42

1.48

1.0

1.1

12.62

43.02

pmol/l

—

Congenital musculoskeletal deformities of head, face, spine and chest

2.25

1.47

1.3

1.4

195.23

207.61

pmol/l

—

Redundant prepuce, phimosis and paraphimosis

212

1786

1.17

1.47

1.2

1.3

185.22

208.26

pmol/l

0.75

212

1786

Malignant neoplasm of rectum, including Hilmo

330

0.60

1.46

1.2

1.4

200.03

197.44

pmol/l

0.03

330

Mixed hyperlipidaemia

132

1.68

1.46

1.8

1.5

138.02

251.90

pmol/l

0.79

132

Periapical abscess

182

2146

0.85

1.46

1.4

1.3

161.04

190.85

pmol/l

1.23

182

2146

Cervicocranial syndrome

227

1.50

1.46

1.3

160.31

165.08

pmol/l

0.09

227

Bicipital tendinitis

179

1.57

1.46

1.9

1.3

165.76

168.00

pmol/l

0.02

179

Arteriovenous malformation of cerebral vessels

2.53

1.46

1.1

1.3

186.96

176.08

pmol/l

—

Mandibular prognathia AND surgery (LeFortI or BSSO), including avohilmo

2.52

1.45

1.1

1.2

241.86

186.83

pmol/l

—

Superficial injury of head

901

0.76

1.45

1.3

189.49

187.32

pmol/l

0.02

901

Postprocedural endocrine and metabolic disorders, not elsewhere classified

195

1.54

1.45

1.3

1.4

129.41

215.19

pmol/l

1.00

195

Malignant neoplasm of prostate, including Hilmo

145

1033

0.83

1.45

1.3

1.4

131.37

177.55

pmol/l

3.45

145

1033

Excessive attrition of teeth

277

2395

1.15

1.44

1.4

1.3

160.56

186.50

pmol/l

1.21

277

2395

Spondylolisthesis/Spondylolysis

489

1.33

1.44

1.4

1.3

163.05

167.62

pmol/l

0.14

489

Postviral fatigue syndrome

3.15

1.44

1.4

1.1

98.18

186.62

pmol/l

—

Other disorders of bone

726

1.27

1.44

1.3

160.01

179.29

pmol/l

0.59

726

Pregnancy hypertension

136

0.46

1.44

1.0

1.1

9.34

26.20

pmol/l

—

136

Other abnormal auditory perceptions

2.75

1.44

1.0

1.2

174.72

171.30

pmol/l

—

Diseases of the respiratory system

270

1173

1.15

1.43

1.4

1.3

159.16

186.47

pmol/l

1.89

270

1173

Malignant neoplasm of testis

118

1.72

1.42

1.3

1.4

128.06

191.90

pmol/l

1.13

118

Chalazion

345

1.39

1.42

1.5

1.4

166.44

190.94

pmol/l

0.36

345

Biological medication for rheuma

796

0.75

1.41

1.4

1.3

153.24

191.52

pmol/l

1.45

796

Invasive ventilation

226

0.53

1.41

1.8

1.4

161.71

205.08

pmol/l

0.38

226

Benign neoplasm of colon, rectum, anus and anal canal

231

1685

1.16

1.41

1.4

1.3

159.89

170.77

pmol/l

0.62

231

1685

Other noninfective gastroenteritis and colitis

692

1.27

1.41

1.5

1.3

155.08

185.12

pmol/l

0.96

692

Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis

103

1.76

1.41

1.6

1.3

158.22

160.27

pmol/l

0.02

103

Diverticular disease of intestine

291

1585

1.14

1.41

1.4

1.3

152.47

178.06

pmol/l

2.29

291

1585

Nutritional anaemias

1080

0.79

1.41

1.2

1.4

134.97

167.34

pmol/l

1.21

1080

Other/unspecified enthesopathies, not elsewhere classified

213

1.51

1.40

1.2

1.3

142.11

165.72

pmol/l

0.68

213

Bronchitis

494

2675

1.11

1.40

1.4

1.3

166.02

179.37

pmol/l

1.33

494

2675

Enteropathic arthropathies

2.19

1.40

1.3

143.17

168.54

pmol/l

—

Spasmodic torticollis

2.26

1.40

1.7

1.3

164.42

158.40

pmol/l

—

Cyst of kidney

165

1.58

1.40

1.9

1.4

176.35

209.74

pmol/l

0.24

165

Acute appendicitis, no complications

295

2580

1.14

1.40

1.4

1.3

173.53

186.91

pmol/l

0.55

295

2580

Suppurative and necrotic conditions of lower respiratory tract

178

0.50

1.39

1.0

1.4

198.16

218.08

pmol/l

—

178

Other specified and unspecified strabismus

2.43

1.39

1.1

1.3

106.27

185.73

pmol/l

—

Collagenous colitis

181

1.55

1.39

1.8

1.4

176.15

215.11

pmol/l

0.30

181

Congenital musculoskeletal deformities of head, face, spine and chest, including avohilmo

2.10

1.39

1.3

1.4

179.86

210.33

pmol/l

0.32

Stomatitis and related lesions

615

1.29

1.38

1.4

1.3

156.71

183.90

pmol/l

0.74

615

Retention of urine

969

0.80

1.38

1.5

1.3

147.43

177.43

pmol/l

1.30

969

Melanocytic naevi of scalp and neck

2.01

1.38

2.4

1.5

208.13

174.00

pmol/l

0.68

Benign neoplasm of mouth and pharynx

288

1.43

1.38

1.1

1.4

169.67

191.13

pmol/l

0.27

288

Adenocarcinoma and papilloma adenocarcinoma of rectum

275

0.58

1.38

1.2

1.4

183.72

202.61

pmol/l

0.21

275

Adrenocortical insufficiency

2.01

1.38

1.1

1.4

85.38

169.18

pmol/l

1.44

Iron deficiency anaemia secondary to blood loss (chronic)

300

0.60

1.38

1.4

143.59

190.58

pmol/l

0.61

300

Other and/or unspecified nontoxic goitre

2.00

1.38

1.2

153.54

142.82

pmol/l

0.14

Other specified/unspecified disorders of bone/cartilage

1.81

1.37

1.4

1.5

169.16

279.27

pmol/l

0.53

ILD differential diagnosis

399

1784

1.12

1.37

1.4

1.3

163.84

184.45

pmol/l

2.00

399

1784

Adjustment and management of implanted device

433

0.67

1.37

1.2

1.4

189.63

184.76

pmol/l

0.06

433

Family history of other specific disorders

2.63

1.37

1.2

215.00

203.02

pmol/l

—

Conduction disorders

753

0.78

1.36

1.5

1.3

164.84

167.60

pmol/l

0.07

753

Anaemias

690

0.79

1.36

1.3

141.38

198.94

pmol/l

3.03

690

COPD differential diagnosis

399

1785

1.12

1.36

1.4

1.3

163.50

184.45

pmol/l

2.05

399

1785

Migraine without aura

382

1.36

1.2

1.3

123.74

166.47

pmol/l

1.75

382

Symptoms and signs involving cognition, perception, emotional state and behaviour

363

2715

0.89

1.35

1.4

1.3

145.14

186.58

pmol/l

3.35

363

2715

Other neurological diseases

209

1879

0.86

1.35

1.4

1.3

143.74

173.07

pmol/l

2.85

209

1879

Malignant neoplasm of head and neck

273

0.58

1.35

1.2

1.4

154.74

204.40

pmol/l

0.64

273

GASTRO-related operations

415

1864

1.12

1.35

1.3

167.70

191.34

pmol/l

2.56

415

1864

Any gastric operation

415

1864

1.12

1.35

1.3

167.70

191.34

pmol/l

2.56

415

1864

N06DA Anticholinesterases

334

0.67

1.35

1.0

1.4

121.54

150.56

pmol/l

0.75

334

Use of anticholinesterases

334

0.67

1.35

1.0

1.4

121.54

150.56

pmol/l

0.75

334

Certain infectious and parasitic diseases, including avohilmo

340

1508

1.13

1.34

1.4

1.3

190.79

200.63

pmol/l

0.12

340

1508

Other and unspecified disorders of psychological development

0.00

1.34

0.0

1.3

—

216.39

—

Clubfoot

0.00

1.34

0.0

1.5

—

191.88

—

Alcohol-induced chronic pancreatitis

346

0.63

1.34

1.2

1.4

200.96

197.33

pmol/l

0.04

346

Poisoning by medicine, drug-induced

0.00

1.34

0.0

1.3

—

167.23

—

Pain associated with micturition

232

1.47

1.33

1.3

1.4

143.05

204.09

pmol/l

0.78

232

Anankastic personality disorder

105

1.72

1.33

1.1

1.4

169.64

159.54

pmol/l

0.14

105

Other/unspecified dorsalgia

142

1171

1.20

1.33

1.5

1.3

170.99

169.55

pmol/l

0.05

142

1171

Effects of other external causes

136

1.63

1.33

1.3

1.4

190.77

182.81

pmol/l

0.12

136

Small cell lung cancer

0.00

1.32

0.0

1.3

—

156.60

—

Small cell lung cancer, including Hilmo

0.00

1.32

0.0

1.4

—

156.60

—

Dysplasia of cervi uteri

2.09

1.32

1.1

9.47

14.09

pmol/l

1.04

Erectile dysfunction

266

1.43

1.32

1.5

1.4

140.52

200.71

pmol/l

0.91

266

Malignant neoplasm of prostate

141

999

0.83

1.32

1.3

130.49

177.55

pmol/l

3.44

141

999

Dermatographic urticaria

113

1.69

1.31

1.1

1.3

194.28

155.70

pmol/l

0.72

113

Alcoholic gastritis

0.00

1.31

0.0

1.3

—

140.55

—

Melanocytic naevi of trunk

359

1.37

1.31

1.4

148.07

185.61

pmol/l

0.68

359

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

283

0.60

1.31

1.2

1.4

187.74

202.10

pmol/l

0.16

283

Intestinal stricture

865

0.77

1.31

1.2

1.3

162.07

175.98

pmol/l

0.34

865

Effects of foreign body entering through natural orifice

117

1418

0.82

1.31

1.3

170.95

186.76

pmol/l

0.40

117

1418

Other sexually transmitted chlamydial diseases

275

1.42

1.30

1.4

1.3

204.32

176.43

pmol/l

0.81

275

Vertigo of central origin

2.51

1.30

1.2

1.3

192.37

173.80

pmol/l

—

Malignant neoplasm of head and neck, including Hilmo

319

0.63

1.30

1.2

1.4

160.54

199.97

pmol/l

0.59

319

Migraine

156

1022

1.19

1.30

1.5

1.3

142.54

181.70

pmol/l

3.93

156

1022

Polyarthritis, unspecified

1.85

1.30

1.4

1.2

183.50

166.03

pmol/l

0.30

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

160

1355

1.18

1.29

1.4

1.3

175.24

187.61

pmol/l

0.38

160

1355

Delirium, not induced by alcohol and other psychoactive substances

269

0.59

1.29

1.3

1.4

150.19

197.14

pmol/l

0.56

269

Presence of other functional implants

146

1189

0.84

1.29

1.4

1.3

219.19

168.41

pmol/l

0.37

146

1189

Tobacco use

193

0.52

1.29

1.3

1.4

135.77

206.92

pmol/l

—

193

Other diseases of anus and rectum

100

806

1.24

1.29

1.6

1.3

144.34

180.53

pmol/l

1.39

100

806

Other disorders of breast

2.35

1.29

1.0

1.2

6.38

14.81

pmol/l

—

Cerebral cysts

161

1.56

1.28

1.4

1.3

103.62

219.80

pmol/l

1.28

161

Contact with machinery

641

1.27

1.28

1.2

1.4

162.77

188.76

pmol/l

0.76

641

Anisometropia and aniseikonia

2.09

1.28

1.3

172.15

183.25

pmol/l

—

Biological medicines for asthma

2.01

1.27

1.4

1.3

163.89

172.87

pmol/l

0.10

Hyperaldosteronism

2.01

1.27

1.3

87.45

166.90

pmol/l

2.15

Other and unspecified erythematous conditions

2.01

1.27

1.3

1.4

160.77

172.37

pmol/l

0.11

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

2.01

1.27

1.1

1.4

157.35

174.66

pmol/l

0.20

Wide developmental disorders

145

1.59

1.27

1.1

1.3

99.87

189.32

pmol/l

2.54

145

Diseases of oesophagus, stomach and duodenum

505

2712

1.10

1.26

1.4

1.3

160.53

186.88

pmol/l

1.56

505

2712

Secondary uncertain malignant neoplasm

377

0.66

1.26

1.1

1.3

125.83

195.12

pmol/l

1.56

377

Nonsuppurative otitis media, including avohilmo

154

1125

1.18

1.26

1.4

1.3

178.93

193.46

pmol/l

0.56

154

1125

Volume depletion

217

0.55

1.26

1.3

1.4

85.13

220.86

pmol/l

2.08

217

Persons encountering health services for other counselling and medical advice, not elsewhere classified

482

2815

0.91

1.26

1.5

1.3

160.82

187.20

pmol/l

1.84

482

2815

Diseases of the skin and subcutaneous tissue

502

2290

1.10

1.25

1.4

1.3

167.30

193.79

pmol/l

1.36

502

2290

Bruxism

2.41

1.24

1.2

135.42

182.84

pmol/l

—

Other disorders starting during childhood or adolescence

158

0.50

1.24

1.5

1.3

239.03

197.68

pmol/l

—

158

Intracranial trauma

282

1682

1.13

1.24

1.4

1.3

173.71

189.68

pmol/l

0.97

282

1682

Hydrocele

555

1.28

1.24

1.3

177.54

188.56

pmol/l

0.22

555

Major coronary heart disease event

324

2171

0.89

1.24

1.5

1.3

155.91

188.34

pmol/l

1.68

324

2171

Desensitization to allergens

179

1.51

1.23

1.2

1.3

186.43

176.44

pmol/l

0.15

179

Scabies

215

0.56

1.23

1.9

1.4

136.35

167.58

pmol/l

0.45

215

Appendectomy

304

2577

1.12

1.22

1.4

1.3

168.46

187.84

pmol/l

0.91

304

2577

Tumor necrosis factor alpha inhibitors

686

0.76

1.22

1.4

1.3

154.67

189.99

pmol/l

1.12

686

Congenital malformations of the circulatory system

506

1.29

1.21

1.4

1.3

163.59

191.85

pmol/l

0.65

506

Other deformities of toe(s)

2.17

1.21

1.6

1.2

172.29

163.71

pmol/l

—

Bilateral sagittal split ramus osteotomy operation

1.80

1.21

1.1

1.4

227.40

154.14

pmol/l

1.87

Polyarthropathies

240

1754

0.88

1.20

1.4

1.3

149.51

194.80

pmol/l

2.21

240

1754

Certain infectious and parasitic diseases

468

2129

1.10

1.20

1.4

1.3

178.98

193.64

pmol/l

0.27

468

2129

Thyroiditis, ILD-related definition

172

1.51

1.20

1.3

136.63

205.24

pmol/l

0.59

172

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

362

2540

0.90

1.19

1.3

193.40

180.80

pmol/l

0.18

362

2540

Oral lichen planus, including avohilmo , including avohilmo

101

1.69

1.19

1.2

1.4

127.24

156.54

pmol/l

0.48

101

Other disorders of pigmentation

1.84

1.19

1.5

1.3

181.02

165.26

pmol/l

0.21

Syphilis, including avohilmo

109

1.66

1.19

1.4

1.5

188.39

245.65

pmol/l

0.30

109

Syphilis

109

1.66

1.19

1.4

1.5

188.39

245.65

pmol/l

0.30

109

Other and unspecified polyneuropathies, also in other diseases

585

1.27

1.19

1.3

139.54

178.16

pmol/l

1.23

585

Second line medication for Crohn's disease

191

2197

0.87

1.19

1.3

151.31

189.50

pmol/l

2.05

191

2197

Flatulence and related conditions

2.33

1.19

1.0

1.2

114.12

178.72

pmol/l

—

Spondylopathies

350

1855

1.12

1.19

1.4

1.3

159.20

189.28

pmol/l

1.29

350

1855

Other/unspecified synovitis and tenosynovitis

306

1.38

1.19

1.3

161.06

167.68

pmol/l

0.14

306

Other viral hepatitis

347

0.66

1.19

1.2

1.4

157.07

203.63

pmol/l

0.60

347

Diabetic retinopathy, excluding more controls

404

0.76

1.19

1.3

1.5

124.56

155.16

pmol/l

0.61

404

Benign neoplasm: Colon

186

1508

1.16

1.18

1.4

1.3

158.01

170.61

pmol/l

0.66

186

1508

Benign neoplasm: Ascending colon

315

1.37

1.18

1.2

1.4

184.94

194.28

pmol/l

0.10

315

Varicose veins

109

994

0.83

1.18

1.3

1.4

151.03

158.99

pmol/l

0.37

109

994

Injuries to the head

533

2896

1.09

1.17

1.4

1.3

183.77

184.59

pmol/l

0.03

533

2896

Aortic valve malfunction, age under 60 years

487

0.72

1.17

1.2

1.4

128.60

186.97

pmol/l

1.75

487

Abnormal blood-pressure reading, without diagnosis

1.71

1.17

2.2

1.5

159.84

176.59

pmol/l

0.22

Other infective otitis externa

149

1.55

1.17

2.0

1.4

147.88

230.00

pmol/l

0.66

149

Other and unspecified acne

2.02

1.17

1.5

1.3

153.48

192.78

pmol/l

—

Exposure to uncontrolled fire in building or structure

0.00

1.17

0.0

1.3

—

166.94

—

Other and unspecified injuries of thorax

2.01

1.17

1.4

1.2

155.82

182.56

pmol/l

—

Other special examinations and investigations of persons without complaint or reported diagnosis

352

1599

1.12

1.16

1.4

1.3

176.69

200.39

pmol/l

0.75

352

1599

Alcohol induced polyneuropathy

0.00

1.16

0.0

1.2

—

164.62

—

Pyothorax

128

0.47

1.16

1.0

1.4

232.28

232.12

pmol/l

—

128

Small cell lung cancer, helper endpoint

0.00

1.16

0.0

1.2

—

139.45

—

Respiratory TBC, ICD-8 codes not specifying whether confirmed bacteriologically or histologically

0.00

1.16

0.0

1.2

—

154.16

—

Unspecified visual impairment (binocular)

0.00

1.16

0.0

1.2

—

180.60

—

Malignant neoplasm of eye and adnexa, including Hilmo

0.00

1.16

0.0

1.2

—

174.01

—

Asthma, unspecified (mode)

179

1494

0.86

1.16

1.3

156.95

184.36

pmol/l

1.93

179

1494

Hypospadias

2.55

1.16

1.4

1.1

281.40

201.47

pmol/l

—

Influenza and pneumonia

443

2998

0.91

1.16

1.3

158.78

188.83

pmol/l

2.06

443

2998

Benign neoplasm: Testis

2.55

1.16

2.0

1.3

105.04

192.84

pmol/l

—

Abnormality of white blood cells, not elsewhere classified

2.52

1.15

1.0

1.2

170.84

181.17

pmol/l

—

Autoimmune thyroiditis

2.51

1.15

1.2

159.22

142.55

pmol/l

—

Fracture of forearm

147

1547

0.85

1.15

1.3

180.33

184.50

pmol/l

0.10

147

1547

Suggestive for eosinophilic asthma

291

1.38

1.15

1.3

1.4

169.18

200.78

pmol/l

0.44

291

Acute gastritis

174

1.50

1.15

1.2

1.4

176.90

210.19

pmol/l

0.26

174

Spondyloarthritis

651

1.25

1.14

1.2

1.4

167.48

186.32

pmol/l

0.50

651

Uterine polyps

2.66

1.14

1.0

11.58

10.00

pmol/l

—

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

142

1.56

1.14

1.6

1.4

137.75

158.47

pmol/l

0.50

142

Other gastritis (incl. Duodenitis)

610

0.75

1.13

1.2

1.3

190.44

181.09

pmol/l

0.18

610

Other/unspecified soft tissue disorders related to use, overuse and pressure

1.85

1.13

1.2

1.4

330.28

149.90

pmol/l

0.62

Other secondary coxarthrosis

1.85

1.13

1.1

1.2

136.70

158.98

pmol/l

0.31

Viral hepatitis, including avohilmo

402

0.69

1.13

1.2

1.4

160.15

198.71

pmol/l

0.54

402

Asthma-related pneumonia or sepsis

1041

0.81

1.13

1.4

1.3

139.06

180.43

pmol/l

2.19

1041

Asthma, hospital admissions 3, pneumonia

1041

0.81

1.13

1.4

1.3

139.06

180.43

pmol/l

2.19

1041

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

180

0.54

1.13

1.4

1.3

253.32

188.02

pmol/l

—

180

Endometriosis of pelvic peritoneum

2.36

1.13

1.1

1.0

6.49

13.36

pmol/l

—

Panic disorder

510

1.28

1.12

1.3

160.99

174.57

pmol/l

0.41

510

Dislocation, sprain and strain of joints and ligaments of elbow

208

1.45

1.12

1.3

1.4

161.36

218.40

pmol/l

0.61

208

Foreign body in respiratory tract

113

0.44

1.12

1.4

130.84

157.32

pmol/l

—

113

Asthma-related pneumonia

1040

0.81

1.12

1.4

1.3

139.06

180.35

pmol/l

2.19

1040

Hypertrophic disorders of skin

111

1.63

1.12

1.3

1.2

149.11

154.71

pmol/l

0.07

111

Injuries to the neck

112

934

1.20

1.12

1.4

1.3

177.63

180.78

pmol/l

0.07

112

934

Explicit bacterial Sepsis, including avohilmo

354

0.68

1.12

1.4

176.46

197.49

pmol/l

0.25

354

Soft tissue disorders related to use, overuse and pressure

104

861

1.21

1.12

1.7

1.3

177.45

170.83

pmol/l

0.13

104

861

L02BA Anti-estrogens

2.00

1.12

1.1

1.3

208.14

73.52

pmol/l

—

Scissor bite

1.80

1.12

1.2

1.3

142.95

195.08

pmol/l

0.65

Ptosis of eyelid

200

1.45

1.11

1.8

1.4

193.78

202.10

pmol/l

0.05

200

Lichen ruber planus, wide definition including periferal and oral lichen planus

493

1.28

1.11

1.3

139.01

185.80

pmol/l

1.38

493

Disorders of eyelid, lacrimal system and orbit

332

2188

1.11

1.4

1.3

165.31

184.67

pmol/l

0.70

332

2188

Asthma, unspecified (mode), excluding more controls

179

1475

0.87

1.11

1.3

156.95

184.73

pmol/l

1.96

179

1475

Migraine without aura and triptan purchases

276

1.38

1.11

1.3

118.67

174.41

pmol/l

0.82

276

Olecranon bursitis

302

1.36

1.11

1.8

1.3

148.95

171.20

pmol/l

0.66

302

Unspecified privation

329

0.67

1.10

1.6

1.4

155.75

194.45

pmol/l

0.61

329

Artificial joint re-operation

1.67

1.10

1.5

1.3

137.53

151.67

pmol/l

0.17

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

313

2036

0.90

1.10

1.4

1.3

163.22

182.61

pmol/l

1.29

313

2036

313

2036

0.90

1.10

1.4

1.3

163.22

182.61

pmol/l

1.29

313

2036

Cardiac murmurs and other cardiac sounds

174

1.48

1.09

1.3

1.4

174.34

181.03

pmol/l

0.11

174

Disorders of calcium metabolism

136

0.51

1.09

1.3

1.5

164.07

243.26

pmol/l

—

136

Other bursitis, not elsewhere classified

2.40

1.09

1.0

1.2

148.30

169.30

pmol/l

—

Hypo-osmolality and hyponatraemia

419

0.71

1.09

1.4

1.3

90.06

192.08

pmol/l

3.40

419

Female infertility, cervical, vaginal, other or unspecified origin

1.87

1.09

1.3

1.1

9.63

14.47

pmol/l

1.50

Oral lichen planus or lichen planus, and hypothyroidism or thyroxine medication

1.95

1.08

1.1

1.2

95.03

132.81

pmol/l

—

Intracerebral haemorrhage

268

0.63

1.08

1.8

1.4

129.46

197.70

pmol/l

1.04

268

Focal epilepsy, strict definition

650

0.77

1.08

1.2

1.3

197.59

184.27

pmol/l

0.13

650

Mandibular retrognathia AND surgery (BSSO)

1.87

1.07

1.1

1.3

229.15

160.76

pmol/l

1.23

Other disorders of nervous system

193

0.57

1.07

1.3

1.4

142.35

209.64

pmol/l

0.45

193

Reimbursement for rheumatic diseases

148

1708

0.86

1.06

1.2

1.3

156.18

175.26

pmol/l

1.22

148

1708

478

2219

1.09

1.06

1.4

1.3

159.31

181.85

pmol/l

2.89

478

2219

Speech therapy

637

0.77

1.06

1.3

168.46

180.20

pmol/l

0.24

637

Disorders of male genital organs in diseases classified elsewhere

2.15

1.06

1.1

1.2

160.29

185.68

pmol/l

—

Concussion

242

1664

1.13

1.06

1.4

1.3

163.87

189.16

pmol/l

2.58

242

1664

Hereditary ataxia

2.14

1.06

1.1

1.3

146.20

160.48

pmol/l

—

Other viral diseases, not elsewhere classified

683

1.23

1.06

1.3

151.90

189.93

pmol/l

1.30

683

Codes for special purposes

164

1872

0.87

1.05

1.4

1.3

159.72

189.04

pmol/l

1.04

164

1872

Provisional assignment of new diseases of uncertain etiology

164

1872

0.87

1.05

1.4

1.3

159.72

189.04

pmol/l

1.04

164

1872

Malignant neoplasm of oesophagus, including Hilmo

121

0.49

1.05

1.3

1.4

76.03

236.59

pmol/l

—

121

Fenamates

165

1.40

1.05

1.3

158.34

159.08

pmol/l

0.01

165

ILD, hospital admission 2, with pulmonary infections

229

0.61

1.05

1.4

1.3

121.73

208.91

pmol/l

1.07

229

Loose body in joint

1.80

1.05

1.2

177.72

182.35

pmol/l

0.05

Zoster [herpes zoster], including avohilmo

162

1353

1.16

1.04

1.5

1.3

166.46

173.13

pmol/l

0.26

162

1353

Struck by thrown, projected or falling objec

254

1.38

1.04

1.4

148.25

207.45

pmol/l

0.88

254

Other hearing loss

534

1.25

1.04

1.6

1.3

156.35

181.46

pmol/l

0.61

534

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

216

0.60

1.04

1.6

1.4

153.18

164.36

pmol/l

0.09

216

L04AX Other immunosuppressants

183

2087

0.88

1.04

1.3

152.03

189.68

pmol/l

1.86

183

2087

Benign lipomatous neoplasm

106

887

1.20

1.04

1.3

1.4

157.05

176.99

pmol/l

0.76

106

887

Toxic effect of other gases, fumes and vapours

2.30

1.04

1.6

1.1

119.74

159.81

pmol/l

—

Gastroduodenal ulcer

666

0.78

1.04

1.4

1.3

146.16

177.67

pmol/l

0.88

666

Liposarcoma

2.29

1.04

1.6

1.2

119.30

170.99

pmol/l

—

Somatoform disorder

419

1.29

1.04

1.2

1.3

160.53

165.43

pmol/l

0.08

419

Macular cyst

1.96

1.03

1.2

1.1

172.74

160.01

pmol/l

—

Abnormal results of function studies

263

1.37

1.03

1.4

226.98

200.63

pmol/l

0.18

263

L02BX Other hormone antagonists and related agents

146

1.51

1.03

1.2

1.4

69.50

155.06

pmol/l

3.01

146

Varicella [chickenpox]

272

1.37

1.03

1.6

1.4

167.88

204.52

pmol/l

0.47

272

Perichondritis of external ear

2.07

1.03

2.0

1.3

131.14

166.48

pmol/l

—

Contusion of ankle

138

1.53

1.03

1.3

1.4

196.73

177.77

pmol/l

0.25

138

Femoral hernia

1.84

1.03

1.3

1.4

178.05

176.61

pmol/l

0.01

Diseases of inner ear

170

1415

1.15

1.02

1.3

156.20

169.41

pmol/l

0.64

170

1415

Disorders of conjunctiva

367

2585

1.10

1.02

1.3

175.87

189.39

pmol/l

0.57

367

2585

Injuries to the elbow and forearm

253

2424

0.89

1.02

1.3

179.38

190.46

pmol/l

0.34

253

2424

Non-invasive ventilation

938

0.83

1.02

1.3

163.99

186.90

pmol/l

1.28

938

Other secondary gonarthrosis

114

1.58

1.02

1.1

1.4

180.41

160.79

pmol/l

0.32

114

Malignant neoplasm of urinary organs, including Hilmo

335

0.69

1.02

1.3

1.4

192.76

196.41

pmol/l

0.03

335

Glomerulonephritis

323

0.68

1.02

1.3

1.4

173.75

193.96

pmol/l

0.25

323

Sacrococcygeal disorders, not elsewhere classified

1.92

1.02

1.1

1.2

189.32

164.83

pmol/l

—

Acute lymphadenitis

196

1.43

1.02

1.1

1.3

170.65

211.54

pmol/l

0.38

196

Other general symptoms and signs

113

1.58

1.02

1.6

1.3

185.47

167.51

pmol/l

0.19

113

Liquid cancers, including Hilmo

1015

0.83

1.02

1.4

138.42

179.97

pmol/l

1.90

1015

Duodenal ulcer

263

0.65

1.01

1.4

182.75

193.75

pmol/l

0.10

263

Non-small cell lung cancer, adenocarcinoma

107

0.47

1.01

1.0

1.3

118.42

153.02

pmol/l

—

107

Sequelae of injuries of lower limb

351

1.31

1.00

1.3

1.4

175.40

198.17

pmol/l

0.33

351

Other diseases of the digestive system

1007

0.82

1.00

1.4

176.76

174.04

pmol/l

0.04

1007

Medical treatment for female infertility

1.65

1.00

1.2

1.1

8.15

12.00

pmol/l

1.60

Cerebral palsy and other paralytic syndromes

310

0.68

1.00

1.4

137.78

190.97

pmol/l

0.81

310

Malignant melanoma

392

0.71

1.00

1.2

1.4

185.46

187.38

pmol/l

0.02

392

Explicit bacterial Sepsis

345

0.69

1.00

1.4

176.46

199.47

pmol/l

0.28

345

Routine general health check-up of defined subpopulation

2.01

1.00

1.7

1.5

179.30

176.55

pmol/l

—

Other abnormal uterine and vaginal bleeding

0.00

1.00

0.0

1.0

—

14.47

—

Symptoms and signs involving the digestive system and abdomen

542

2510

1.08

1.00

1.4

1.3

172.40

192.48

pmol/l

1.00

542

2510

Iron deficiency anaemia

933

0.82

0.99

1.2

1.3

131.83

168.24

pmol/l

1.21

933

Candidiasis

308

1.33

0.99

1.2

1.4

162.84

184.57

pmol/l

0.25

308

Orchitis and epididymitis

529

1.25

0.99

1.4

1.3

179.08

198.68

pmol/l

0.43

529

Major anomalies of jaw size

1.72

0.99

1.2

1.5

161.00

172.14

pmol/l

0.17

Subarachnoid haemorrhage

237

0.63

0.98

1.2

1.4

161.91

206.83

pmol/l

0.54

237

Benign neoplasm: Tongue

1.84

0.98

1.2

1.3

176.23

162.34

pmol/l

—

Cholecystectomy

198

1482

1.13

0.98

1.2

1.3

154.54

167.22

pmol/l

0.67

198

1482

Focal epilepsy, mode (most common among epilepsy diagnosis)

606

0.77

0.98

1.2

1.3

199.38

183.30

pmol/l

0.15

606

Thyrotropin deficiency

2.19

0.98

1.6

1.3

110.10

168.88

pmol/l

—

Viral infections of the central nervous system, including avohilmo

223

1.39

0.98

1.3

1.4

136.25

208.81

pmol/l

0.98

223

Malignant neoplasm of bone and articular cartilage of limbs, including Hilmo

0.00

0.98

0.0

1.2

—

179.44

—

Dependence on enabling machines and devices, not elsewhere classified

0.00

0.98

0.0

1.3

—

180.30

—

Malignant neoplasm of renal pelvis, including Hilmo

0.00

0.98

0.0

1.2

—

163.94

—

Crushed, pushed or stepped on by crowd or human stampede

388

1.29

0.98

1.2

1.4

192.12

205.34

pmol/l

0.19

388

Lung transplant status

0.00

0.98

0.0

1.3

—

166.68

—

Lung transplantation

0.00

0.98

0.0

1.3

—

166.68

—

Acute laryngitis and tracheitis

575

1.24

0.97

1.4

1.3

203.93

212.11

pmol/l

0.14

575

Progressive vascular leukoencephalopathy

0.00

0.97

0.0

1.1

—

163.30

—

Disorders of puberty

1.95

0.97

1.0

1.1

83.63

218.81

pmol/l

—

Injury of urinary and pelvic organs

1.75

0.97

1.6

1.3

182.03

169.70

pmol/l

0.13

Syncope and collapse

146

1405

0.87

0.96

1.3

170.98

172.15

pmol/l

0.04

146

1405

Acquired absence of organs, not elsewhere classified

0.00

0.96

0.0

1.3

—

178.03

—

Gonococcal infection, including avohilmo

108

1.58

0.96

1.4

196.25

167.69

pmol/l

0.50

108

Maternal care for known or suspected abnormality of pelvic organs

0.50

0.96

1.0

1.1

8.15

37.30

pmol/l

—

Peritonsillar abscess

102

858

1.19

0.96

1.2

1.3

163.62

187.58

pmol/l

0.99

102

858

Benign neoplasm: Adrenal gland

174

0.57

0.96

1.0

1.5

117.93

211.63

pmol/l

—

174

Covid-19 confirmed case

1152

0.84

0.96

1.5

1.3

158.70

175.80

pmol/l

0.57

1152

Pain, not elsewhere classified

111

941

1.18

0.96

1.3

155.31

171.91

pmol/l

0.71

111

941

Viral infections characterized by skin and mucous membrane lesions

193

1704

1.13

0.95

1.4

1.3

167.21

177.24

pmol/l

0.49

193

1704

Other and unspecified effects of external causes

118

1006

1.17

0.95

1.3

145.65

187.56

pmol/l

2.74

118

1006

Colon adenocarcinoma

259

0.66

0.95

1.2

1.4

146.23

202.54

pmol/l

0.71

259

Conjunctivitis (acute, non atopic), including avohilmo

500

2790

1.08

0.95

1.4

1.3

216.62

178.45

pmol/l

0.34

500

2790

Foreign body in ear

1.77

0.94

1.1

1.3

124.60

180.23

pmol/l

—

Oral corticosteroids

436

2774

0.92

0.94

1.4

1.3

147.55

188.55

pmol/l

3.50

436

2774

Carcinoma in situ of skin of scalp and neck

1.90

0.94

1.1

1.2

255.86

146.08

pmol/l

—

Cervicalgia

560

1.23

0.94

1.5

1.3

149.95

165.64

pmol/l

0.45

560

Polyp of the female genital tract

2.26

0.94

1.0

9.98

11.30

pmol/l

—

Other and unspecified injuries of neck

2.24

0.94

1.3

197.28

174.14

pmol/l

—

Liposarcoma, including Hilmo

2.24

0.94

1.5

1.3

145.08

160.23

pmol/l

—

Complications of procedures, not elsewhere classified

286

2543

0.90

0.93

1.4

1.3

159.70

185.91

pmol/l

1.17

286

2543

Persons encountering health services for specific procedures, not carried out

363

0.71

0.93

1.3

1.4

187.31

195.89

pmol/l

0.09

363

Cardiac arrhythmias

324

1886

1.10

0.93

1.4

1.3

188.08

199.25

pmol/l

0.14

324

1886

Injuries to the thorax

183

2068

0.88

0.93

1.3

162.13

178.37

pmol/l

0.97

183

2068

Otitis externa

742

1.20

0.93

1.5

1.3

141.87

181.14

pmol/l

1.57

742

Nontoxic diffuse goitre

2.23

0.93

1.3

1.1

112.18

152.27

pmol/l

—

Embedded teeth, including avohilmo

303

1.32

0.93

1.2

1.3

180.03

172.33

pmol/l

0.16

303

Other disorders starting during childhood or adolecense, excluding more controls

138

0.55

0.93

1.5

1.3

239.03

210.83

pmol/l

—

138

Chondropathies

552

1.23

0.93

1.2

1.3

156.52

184.77

pmol/l

0.77

552

Seborrhoeic dermatitis

321

1.31

0.92

1.3

151.71

196.50

pmol/l

0.74

321

Traumatic subdural haemorrhage

339

0.72

0.92

1.3

1.4

176.23

179.96

pmol/l

0.08

339

Benign neoplasm: Skin of scalp and neck

1.74

0.92

2.6

1.4

217.62

178.46

pmol/l

—

Other disorders of Eustachian tube

1.74

0.92

1.3

160.07

173.49

pmol/l

—

Ulcerative proctitis

192

1.41

0.92

1.4

1.3

152.90

213.64

pmol/l

0.59

192

Other ulcerative colitis

209

1.39

0.92

1.1

1.4

199.32

206.97

pmol/l

0.05

209

Emergency coronary revascularization (for ACS)

328

2172

0.91

0.92

1.5

1.3

156.33

187.79

pmol/l

1.60

328

2172

Accidents

357

1631

1.10

0.91

1.3

164.62

197.42

pmol/l

1.15

357

1631

Urticaria and erythema

117

1001

1.17

0.91

1.3

156.52

178.05

pmol/l

0.88

117

1001

Symptoms and signs involving the urinary system

334

2296

1.10

0.91

1.4

1.3

161.28

177.87

pmol/l

1.11

334

2296

Intussusception

2.15

0.91

1.0

1.5

243.17

173.31

pmol/l

—

Acute peritonitis

171

0.58

0.91

1.3

1.4

136.10

222.09

pmol/l

—

171

Follow-up examination after treatment for malignant neoplasms

126

1.51

0.91

1.1

1.4

105.44

155.47

pmol/l

1.42

126

Viral conjunctivitis, including avohilmo

1.63

0.91

1.2

1.4

121.49

177.01

pmol/l

1.06

Amblyopia ex anopsia

1.63

0.91

1.5

1.2

180.79

184.25

pmol/l

0.03

Gonococcal infection

1.60

0.90

1.4

182.41

167.39

pmol/l

0.23

Other epidermal thickening

1.60

0.90

1.3

160.29

172.34

pmol/l

0.14

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

486

0.76

0.90

1.1

1.3

128.35

186.63

pmol/l

1.36

486

Anosmia

1.81

0.90

1.2

1.4

179.90

196.31

pmol/l

—

Infliximab

101

0.49

0.90

1.2

1.3

190.90

191.11

pmol/l

—

101

Disorders of breast

118

1.49

0.89

1.0

1.1

101.70

12.51

pmol/l

0.45

118

Congenital malformations of the musculoskeletal system, not elsewhere classified, including avohilmo

2.08

0.89

1.7

1.1

53.45

178.89

pmol/l

—

Malignant neoplasm of oral cavity

103

0.48

0.89

1.6

1.5

140.52

160.62

pmol/l

—

103

Intracranial injury

227

2354

0.90

0.89

1.5

1.3

167.35

190.20

pmol/l

0.94

227

2354

Benign neoplasm: Caecum

202

1.39

0.89

1.3

1.5

205.74

201.26

pmol/l

0.03

202

Ischemic heart diseases

334

2175

0.91

0.89

1.5

1.3

156.63

188.97

pmol/l

1.67

334

2175

Disorders of puberty, all

1.91

0.88

1.0

1.1

111.17

206.80

pmol/l

—

Thiazolidinediones

359

0.72

0.88

1.9

1.4

110.41

177.46

pmol/l

2.71

359

Retinoschisis and retinal cysts

1.91

0.88

1.3

1.2

143.63

164.16

pmol/l

—

Venous thromboembolism

138

1524

0.87

0.88

1.4

1.3

234.42

164.60

pmol/l

0.52

138

1524

Postpartum haemorrhage due to retained placenta

1.91

0.88

1.0

1.1

8.82

11.54

pmol/l

—

Triptan medication for migraine, min. 3 purchases

176

1160

1.13

0.88

1.3

145.00

175.77

pmol/l

1.88

176

1160

Chronic ulcer of skin, not elsewhere classified

154

0.58

0.88

1.0

1.5

116.51

226.92

pmol/l

—

154

Gonarthrosis [arthrosis of knee](FG)

332

1742

1.10

0.88

1.4

1.3

181.17

171.35

pmol/l

0.14

332

1742

Malignant neoplasm of stomach, including Hilmo

127

0.55

0.88

1.0

1.4

139.04

218.83

pmol/l

—

127

Viral infections of the central nervous system

211

1.38

0.88

1.2

1.4

135.61

210.80

pmol/l

0.96

211

Helminthiases, including avohilmo

1.65

0.88

1.5

1.3

146.62

165.97

pmol/l

0.26

Other osteochondropathies

289

1.32

0.88

1.2

1.4

160.82

199.08

pmol/l

0.55

289

Other peripheral vascular diseases

152

1.45

0.88

1.5

1.4

170.80

217.81

pmol/l

0.34

152

Complications of other internal prosthetic devices, implants and grafts

1.79

0.88

1.5

1.2

103.21

147.37

pmol/l

—

Cluster headache, strict

111

1.54

0.87

1.6

1.4

166.49

181.82

pmol/l

0.18

111

Superficial injury of hip and thigh

368

1.28

0.87

1.4

156.46

187.61

pmol/l

0.55

368

Viral infections of central nervous system, not elsewhere classified/unspecifie, including avohilmod

1.87

0.87

1.6

1.5

179.39

174.86

pmol/l

—

Other and unspecified injuries of abdomen, lower back and pelvis

1.87

0.87

1.3

1.4

158.86

181.98

pmol/l

—

Other external causes of accidental injury

356

1631

1.09

0.87

1.3

165.23

197.42

pmol/l

1.12

356

1631

Other metabolic disorders

237

1.35

0.87

1.3

1.4

133.95

206.75

pmol/l

0.99

237

Delivery

0.55

0.87

1.1

13.23

43.02

pmol/l

—

Crohn disease (strict definition, require KELA, min 2 HDR)

241

0.66

0.87

1.4

1.3

148.12

177.43

pmol/l

0.71

241

Other specified/unspecified necrotizing vasculopathies

2.01

0.87

1.7

1.3

111.87

181.32

pmol/l

—

Statin medication

319

1967

0.91

0.87

1.3

184.80

199.43

pmol/l

0.19

319

1967

Viral hepatitis

380

0.73

0.86

1.2

1.4

160.15

200.70

pmol/l

0.56

380

Mycoses

104

887

1.17

0.86

1.3

171.69

176.03

pmol/l

0.10

104

887

Nausea and vomiting

655

0.80

0.86

1.2

1.3

190.59

181.12

pmol/l

0.09

655

Coronary revascularization (ANGIO or CABG)

317

2107

0.91

0.86

1.5

1.3

156.68

188.92

pmol/l

1.59

317

2107

Rheumatic fever incl heart disease

1.82

0.86

1.3

1.2

141.28

178.68

pmol/l

—

Benign neoplasm: Kidney

1.82

0.86

1.6

1.2

142.25

168.98

pmol/l

—

Other contact dermatitis

192

0.62

0.85

1.2

1.4

179.84

161.95

pmol/l

0.24

192

Pain in thoracic spine

432

1.25

0.85

1.4

1.3

176.51

167.43

pmol/l

0.24

432

Melanocytic naevi, other sites/unspecified

221

1.36

0.85

1.6

1.4

188.93

205.82

pmol/l

0.14

221

Hypokalaemia

275

0.69

0.85

1.2

1.4

115.78

206.08

pmol/l

1.37

275

Left ventricular outflow tract obstruction (LVOTO), broad definition

503

0.77

0.85

1.2

1.4

129.43

187.62

pmol/l

1.88

503

Psychotic depression

145

1.45

0.84

1.5

1.4

162.14

180.00

pmol/l

0.25

145

Asymmetry of jaw

1.95

0.84

1.5

1.2

187.83

180.58

pmol/l

—

Conjunctivitis (acute, non atopic)

112

959

1.16

0.84

1.3

155.64

177.92

pmol/l

0.90

112

959

Mandibular prognathia

1.79

0.84

1.1

1.2

213.28

189.72

pmol/l

—

Tooth eruption problems

461

1.24

0.84

1.2

1.4

195.28

176.09

pmol/l

0.57

461

Background retinopathy and retinal vascular changes

1.79

0.84

1.3

1.5

125.53

161.40

pmol/l

—

Other diseases of pancreas

239

0.67

0.84

1.1

1.5

164.12

204.01

pmol/l

0.33

239

Asthma mixed form (mode), excluding more controls

104

1.54

0.84

1.3

170.13

265.72

pmol/l

0.52

104

Biomechanical lesions, not elsewhere classified

1.57

0.84

1.2

1.3

184.74

149.75

pmol/l

0.40

Other and unspecified diseases of blood and blood-forming organs

1.76

0.84

1.4

1.3

134.11

173.79

pmol/l

—

Phlebitis and thrombophlebitis (not including DVT)

633

1.20

0.83

1.4

328.36

164.50

pmol/l

0.74

633

Generalized epilepsy

112

0.53

0.83

1.3

1.4

185.50

162.62

pmol/l

—

112

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Testosterone Free [Moles/volume] in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS